Apellis Pharmaceuticals Inc. (APLS) NASDAQ
$49.84 1.12 (2.30%)
Market Cap: $5.87B
As of 04/24/24 03:59 PM EDT. Market closed.
Apellis Pharmaceuticals Inc. (APLS)
NASDAQ
$49.84
1.12 (2.30%)
Market Cap: $5.87B
As of 04/24/24 03:59 PM EDT. Market closed.
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Dunlop A. Sinclair | Director | Apr 12, 2024 | Option Exercise | $13.19 | 1,500 | 19,785 | 133,518 | Apr 15, 2024, 04:09 PM |
Deschatelets Pascal | Chief Scientific Officer | Apr 08, 2024 | Option Exercise | $3.76 | 69,107 | 259,842 | 1,185,090 | Apr 09, 2024, 04:25 PM |
Deschatelets Pascal | Chief Scientific Officer | Apr 08, 2024 | Sale | $54.17 | 69,107 | 3,743,605 | 1,120,711 | Apr 09, 2024, 04:25 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Apr 01, 2024 | Option Exercise | $10.03 | 4,000 | 40,120 | 97,338 | Apr 02, 2024, 04:06 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Apr 01, 2024 | Sale | $58.66 | 4,000 | 234,640 | 93,338 | Apr 02, 2024, 04:06 PM |
Dunlop A. Sinclair | Director | Mar 19, 2024 | Sale | $57.18 | 18,681 | 1,068,161 | 173,998 | Mar 20, 2024, 05:18 PM |
DeLong Mark Jeffrey | Chief Business & Strat Officer | Mar 18, 2024 | Sale | $56.90 | 9,913 | 564,050 | 54,693 | Mar 19, 2024, 04:03 PM |
Chopas James George | VP/Chief Accounting Officer | Mar 15, 2024 | Sale | $56.46 | 184 | 10,389 | 38,883 | Mar 18, 2024, 04:19 PM |
Nicholson Nur | Chief Technical Officer | Mar 13, 2024 | Sale | $57.56 | 11,220 | 645,838 | 59,739 | Mar 14, 2024, 04:17 PM |
Deschatelets Pascal | Chief Scientific Officer | Mar 08, 2024 | Option Exercise | $3.67 | 69,107 | 253,623 | 1,185,090 | Mar 11, 2024, 04:08 PM |
Deschatelets Pascal | Chief Scientific Officer | Mar 08, 2024 | Sale | $62.19 | 69,107 | 4,297,549 | 1,142,340 | Mar 11, 2024, 04:08 PM |
Watson David O. | General Counsel | Mar 06, 2024 | Option Exercise | $13.85 | 3,762 | 52,104 | 107,152 | Mar 08, 2024, 07:45 AM |
Francois Cedric | Chief Executive Officer | Mar 01, 2024 | Option Exercise | $4.20 | 250,000 | 1,050,000 | 563,662 | Mar 05, 2024, 04:07 PM |
Francois Cedric | Chief Executive Officer | Mar 01, 2024 | Sale | $64.11 | 250,000 | 16,028,706 | 534,794 | Mar 05, 2024, 04:07 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Mar 01, 2024 | Option Exercise | $10.03 | 6,000 | 60,180 | 99,338 | Mar 05, 2024, 04:04 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Mar 01, 2024 | Sale | $63.22 | 6,000 | 379,340 | 95,338 | Mar 05, 2024, 04:04 PM |
Watson David O. | General Counsel | Feb 12, 2024 | Sale | $67.77 | 781 | 52,926 | 103,390 | Feb 13, 2024, 05:06 PM |
Townsend Adam J. | Chief Commercial Officer | Feb 12, 2024 | Sale | $67.77 | 1,148 | 77,796 | 92,453 | Feb 13, 2024, 05:05 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Feb 12, 2024 | Sale | $67.77 | 1,431 | 96,974 | 93,338 | Feb 13, 2024, 04:59 PM |
Francois Cedric | Chief Executive Officer | Feb 12, 2024 | Sale | $67.77 | 3,962 | 268,492 | 313,662 | Feb 13, 2024, 04:49 PM |
Deschatelets Pascal | Chief Scientific Officer | Feb 12, 2024 | Sale | $67.77 | 1,148 | 77,796 | 1,115,983 | Feb 13, 2024, 04:43 PM |
DeLong Mark Jeffrey | Chief Business & Strat Officer | Feb 12, 2024 | Sale | $67.77 | 597 | 40,457 | 64,606 | Feb 13, 2024, 04:38 PM |
Watson David O. | General Counsel | Jan 29, 2024 | Sale | $64.14 | 906 | 58,109 | 104,171 | Jan 31, 2024, 04:38 PM |
Townsend Adam J. | Chief Commercial Officer | Jan 29, 2024 | Sale | $64.14 | 906 | 58,109 | 93,601 | Jan 31, 2024, 04:36 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Jan 29, 2024 | Sale | $64.14 | 906 | 58,109 | 94,769 | Jan 31, 2024, 04:34 PM |
Nicholson Nur | Chief Technical Officer | Jan 29, 2024 | Sale | $64.14 | 835 | 53,555 | 67,507 | Jan 31, 2024, 04:31 PM |
Lewis Karen | Chief People Officer | Jan 30, 2024 | Sale | $65.53 | 883 | 57,863 | 46,387 | Jan 31, 2024, 04:28 PM |
Lewis Karen | Chief People Officer | Jan 29, 2024 | Sale | $64.14 | 367 | 23,539 | 47,270 | Jan 31, 2024, 04:28 PM |
Francois Cedric | Chief Executive Officer | Jan 29, 2024 | Sale | $64.14 | 2,843 | 182,345 | 317,624 | Jan 31, 2024, 04:26 PM |
Eisele Jeffrey | Chief Development Officer | Jan 29, 2024 | Sale | $64.14 | 279 | 17,895 | 58,179 | Jan 31, 2024, 04:23 PM |
Eisele Jeffrey | Chief Development Officer | Jan 30, 2024 | Sale | $65.53 | 971 | 63,630 | 57,208 | Jan 31, 2024, 04:23 PM |
Deschatelets Pascal | Chief Scientific Officer | Jan 29, 2024 | Sale | $64.14 | 874 | 56,057 | 1,117,131 | Jan 31, 2024, 04:21 PM |
DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 29, 2024 | Sale | $64.14 | 367 | 23,539 | 65,203 | Jan 31, 2024, 04:18 PM |
Lewis Karen | Chief People Officer | Jan 23, 2024 | Sale | $63.69 | 4,286 | 272,975 | 47,637 | Jan 24, 2024, 04:06 PM |
Eisele Jeffrey | Chief Development Officer | Jan 23, 2024 | Sale | $63.69 | 7,378 | 469,905 | 58,458 | Jan 24, 2024, 04:03 PM |
Francois Cedric | Chief Executive Officer | Jan 22, 2024 | Sale | $65.00 | 13,431 | 872,961 | 320,467 | Jan 23, 2024, 07:28 PM |
Watson David O. | General Counsel | Jan 22, 2024 | Sale | $65.00 | 4,184 | 271,943 | 105,077 | Jan 23, 2024, 06:17 PM |
Townsend Adam J. | Chief Commercial Officer | Jan 22, 2024 | Sale | $65.00 | 3,413 | 221,831 | 94,507 | Jan 23, 2024, 06:15 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Jan 22, 2024 | Sale | $65.00 | 3,551 | 230,801 | 95,675 | Jan 23, 2024, 06:13 PM |
Nicholson Nur | Chief Technical Officer | Jan 22, 2024 | Sale | $65.00 | 2,593 | 168,535 | 68,342 | Jan 23, 2024, 06:11 PM |
Lewis Karen | Chief People Officer | Jan 22, 2024 | Sale | $65.00 | 1,738 | 112,963 | 51,923 | Jan 23, 2024, 06:07 PM |
Eisele Jeffrey | Chief Development Officer | Jan 22, 2024 | Sale | $65.00 | 1,607 | 104,449 | 65,836 | Jan 23, 2024, 06:05 PM |
Deschatelets Pascal | Chief Scientific Officer | Jan 22, 2024 | Sale | $65.00 | 3,913 | 254,329 | 1,118,005 | Jan 23, 2024, 06:03 PM |
DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 22, 2024 | Sale | $65.00 | 1,384 | 89,954 | 65,570 | Jan 23, 2024, 06:01 PM |
Chopas James George | VP/Chief Accounting Officer | Jan 22, 2024 | Sale | $65.00 | 1,061 | 68,961 | 39,067 | Jan 23, 2024, 06:00 PM |
Eisele Jeffrey | Chief Development Officer | Jan 17, 2024 | Sale | $65.58 | 5,207 | 341,475 | 67,443 | Jan 18, 2024, 04:55 PM |
Lewis Karen | Chief People Officer | Jan 17, 2024 | Sale | $65.58 | 3,276 | 214,840 | 53,661 | Jan 18, 2024, 04:54 PM |
Deschatelets Pascal | Chief Scientific Officer | Jan 16, 2024 | Sale | $66.81 | 1,632 | 109,032 | 1,121,918 | Jan 17, 2024, 04:47 PM |
Chopas James George | VP/Chief Accounting Officer | Jan 16, 2024 | Sale | $66.81 | 864 | 57,723 | 40,128 | Jan 17, 2024, 04:45 PM |
Lewis Karen | Chief People Officer | Jan 16, 2024 | Sale | $66.81 | 1,632 | 109,032 | 56,937 | Jan 17, 2024, 04:43 PM |
DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 16, 2024 | Sale | $66.81 | 1,631 | 108,965 | 66,954 | Jan 17, 2024, 04:41 PM |
Nicholson Nur | Chief Technical Officer | Jan 16, 2024 | Sale | $66.81 | 1,857 | 124,064 | 70,935 | Jan 17, 2024, 04:40 PM |
Watson David O. | General Counsel | Jan 16, 2024 | Sale | $66.81 | 4,240 | 283,268 | 109,261 | Jan 17, 2024, 04:38 PM |
Townsend Adam J. | Chief Commercial Officer | Jan 16, 2024 | Sale | $66.81 | 2,235 | 149,317 | 97,920 | Jan 17, 2024, 04:37 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Jan 16, 2024 | Sale | $66.81 | 2,235 | 149,317 | 99,226 | Jan 17, 2024, 04:36 PM |
Francois Cedric | Chief Executive Officer | Jan 16, 2024 | Sale | $66.81 | 7,851 | 524,514 | 333,898 | Jan 17, 2024, 04:32 PM |
Eisele Jeffrey | Chief Development Officer | Jan 16, 2024 | Sale | $66.81 | 438 | 29,262 | 72,650 | Jan 17, 2024, 12:24 PM |
Baumal Caroline | Chief Medical Officer | Jan 04, 2024 | Sale | $60.05 | 2,751 | 165,207 | 32,931 | Jan 05, 2024, 04:14 PM |
Eisele Jeffrey | Chief Development Officer | Dec 27, 2023 | Sale | $60.23 | 235 | 14,154 | 53,580 | Dec 28, 2023, 04:13 PM |
Eisele Jeffrey | Chief Development Officer | Dec 26, 2023 | Sale | $57.86 | 68 | 3,935 | 53,815 | Dec 28, 2023, 04:13 PM |
Watson David O. | General Counsel | Dec 19, 2023 | Option Exercise | $13.85 | 7,905 | 109,484 | 93,658 | Dec 20, 2023, 04:18 PM |
Watson David O. | General Counsel | Dec 19, 2023 | Sale | $57.23 | 3,905 | 223,472 | 92,053 | Dec 20, 2023, 04:18 PM |
Dunlop A. Sinclair | Director | Dec 14, 2023 | Option Exercise | $13.19 | 6,274 | 82,754 | 128,677 | Dec 15, 2023, 04:04 PM |
SCHEIBLER LUKAS | Chief Research Officer | Dec 01, 2023 | Option Exercise | $13.85 | 10,000 | 138,500 | 78,299 | Dec 05, 2023, 07:40 PM |
SCHEIBLER LUKAS | Chief Research Officer | Dec 01, 2023 | Sale | $60.00 | 10,000 | 600,000 | 68,299 | Dec 05, 2023, 07:40 PM |
Townsend Adam J. | Chief Commercial Officer | Dec 01, 2023 | Option Exercise | $15.09 | 110,000 | 1,659,900 | 186,407 | Dec 05, 2023, 07:29 PM |
Townsend Adam J. | Chief Commercial Officer | Dec 01, 2023 | Sale | $60.81 | 110,000 | 6,689,303 | 118,850 | Dec 05, 2023, 07:29 PM |
Dunlop A. Sinclair | Director | Dec 01, 2023 | Sale | $61.13 | 24,000 | 1,467,240 | 192,679 | Dec 05, 2023, 04:21 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Nov 30, 2023 | Option Exercise | $10.03 | 14,158 | 142,005 | 91,871 | Dec 01, 2023, 04:11 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Nov 30, 2023 | Sale | $54.73 | 14,158 | 774,884 | 78,013 | Dec 01, 2023, 04:11 PM |
Francois Cedric | Chief Executive Officer | Nov 21, 2023 | Sale | $48.80 | 5,000 | 244,000 | 269,655 | Nov 21, 2023, 05:36 PM |
Dunlop A. Sinclair | Director | Nov 17, 2023 | Sale | $49.99 | 8,894 | 444,620 | 122,403 | Nov 21, 2023, 04:36 PM |
Dunlop A. Sinclair | Director | Oct 17, 2023 | Sale | $49.00 | 24,000 | 1,176,000 | 216,679 | Nov 21, 2023, 04:00 PM |
Machiels Alec | Director | Nov 17, 2023 | Option Exercise | $2.67 | 1,250 | 3,338 | 368,670 | Nov 20, 2023, 04:18 PM |
Machiels Alec | Director | Nov 17, 2023 | Sale | $47.74 | 1,250 | 59,675 | 367,420 | Nov 20, 2023, 04:18 PM |
Deschatelets Pascal | Chief Scientific Officer | Nov 14, 2023 | Option Exercise | $3.76 | 45,000 | 169,200 | 1,116,807 | Nov 15, 2023, 04:10 PM |
Deschatelets Pascal | Chief Scientific Officer | Nov 08, 2023 | Option Exercise | $2.67 | 17,494 | 46,709 | 1,083,807 | Nov 09, 2023, 04:18 PM |
Deschatelets Pascal | Chief Scientific Officer | Nov 08, 2023 | Sale | $47.27 | 12,000 | 567,240 | 1,071,807 | Nov 09, 2023, 04:18 PM |
Chopas James George | VP/Chief Accounting Officer | Oct 23, 2023 | Sale | $46.04 | 132 | 6,077 | 32,680 | Oct 24, 2023, 04:20 PM |
DeLong Mark Jeffrey | Chief Business & Strat Officer | Oct 23, 2023 | Sale | $46.04 | 131 | 6,031 | 51,622 | Oct 24, 2023, 04:18 PM |
Machiels Alec | Director | Oct 17, 2023 | Option Exercise | $2.67 | 1,250 | 3,338 | 368,670 | Oct 18, 2023, 05:43 PM |
Machiels Alec | Director | Oct 17, 2023 | Sale | $48.50 | 1,250 | 60,625 | 367,420 | Oct 18, 2023, 05:43 PM |
Deschatelets Pascal | Chief Scientific Officer | Oct 09, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,078,313 | Oct 10, 2023, 04:26 PM |
Deschatelets Pascal | Chief Scientific Officer | Oct 09, 2023 | Sale | $40.38 | 12,000 | 484,560 | 1,066,313 | Oct 10, 2023, 04:26 PM |
Machiels Alec | Director | Sep 18, 2023 | Option Exercise | $2.67 | 1,250 | 3,338 | 368,670 | Sep 19, 2023, 05:05 PM |
Machiels Alec | Director | Sep 18, 2023 | Sale | $45.00 | 1,250 | 56,250 | 367,420 | Sep 19, 2023, 05:05 PM |
Nicholson Nur | Chief Technical Officer | Sep 18, 2023 | Option Exercise | $29.76 | 9,719 | 289,237 | 73,634 | Sep 19, 2023, 05:03 PM |
Nicholson Nur | Chief Technical Officer | Sep 18, 2023 | Sale | $44.27 | 20,350 | 900,813 | 63,915 | Sep 19, 2023, 05:03 PM |
Machiels Alec | Director | Sep 15, 2023 | Option Exercise | $2.67 | 1,250 | 3,338 | 368,670 | Sep 18, 2023, 04:24 PM |
Machiels Alec | Director | Sep 15, 2023 | Sale | $45.34 | 1,250 | 56,675 | 367,420 | Sep 18, 2023, 04:24 PM |
Deschatelets Pascal | Chief Scientific Officer | Sep 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,071,813 | Sep 11, 2023, 04:58 PM |
Deschatelets Pascal | Chief Scientific Officer | Sep 08, 2023 | Sale | $42.87 | 12,000 | 514,440 | 1,059,813 | Sep 11, 2023, 04:58 PM |
SCHEIBLER LUKAS | Chief Research Officer | Sep 06, 2023 | Sale | $43.01 | 1,756 | 75,526 | 68,299 | Sep 07, 2023, 04:08 PM |
Chopas James George | VP/Chief Accounting Officer | Aug 31, 2023 | Sale | $41.23 | 551 | 22,716 | 30,312 | Sep 01, 2023, 04:08 PM |
Francois Cedric | Chief Executive Officer | Sep 01, 2023 | Option Exercise | $2.67 | 300,000 | 801,000 | 574,655 | Sep 01, 2023, 04:05 PM |
Francois Cedric | Chief Executive Officer | Sep 01, 2023 | Sale | $41.75 | 150,000 | 6,262,959 | 434,939 | Sep 01, 2023, 04:05 PM |
Deschatelets Pascal | Chief Scientific Officer | Aug 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,065,313 | Aug 09, 2023, 04:08 PM |
Deschatelets Pascal | Chief Scientific Officer | Aug 08, 2023 | Sale | $23.66 | 12,000 | 283,920 | 1,053,313 | Aug 09, 2023, 04:08 PM |
Machiels Alec | Director | Jul 21, 2023 | Option Exercise | $2.67 | 49,779 | 132,910 | 367,420 | Jul 24, 2023, 05:01 PM |
Machiels Alec | Director | Jul 20, 2023 | Option Exercise | $2.67 | 50,000 | 133,500 | 317,641 | Jul 21, 2023, 04:13 PM |
Machiels Alec | Director | Jul 17, 2023 | Option Exercise | $2.67 | 1,250 | 3,338 | 268,891 | Jul 18, 2023, 04:40 PM |
Machiels Alec | Director | Jul 17, 2023 | Sale | $64.79 | 1,250 | 80,988 | 267,641 | Jul 18, 2023, 04:40 PM |
Deschatelets Pascal | Chief Scientific Officer | Jul 10, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,058,813 | Jul 11, 2023, 05:37 PM |
Deschatelets Pascal | Chief Scientific Officer | Jul 10, 2023 | Sale | $84.55 | 12,000 | 1,014,600 | 1,046,813 | Jul 11, 2023, 05:37 PM |
Watson David O. | General Counsel | Jul 03, 2023 | Sale | $89.98 | 8,510 | 765,730 | 85,753 | Jul 06, 2023, 04:20 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Jul 03, 2023 | Option Exercise | $10.03 | 6,779 | 67,993 | 84,492 | Jul 06, 2023, 04:16 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Jul 03, 2023 | Sale | $89.97 | 6,779 | 609,928 | 81,300 | Jul 06, 2023, 04:16 PM |
Machiels Alec | Director | Jun 20, 2023 | Option Exercise | $2.67 | 1,250 | 3,338 | 268,891 | Jun 21, 2023, 04:34 PM |
Machiels Alec | Director | Jun 20, 2023 | Sale | $88.41 | 1,250 | 110,513 | 267,641 | Jun 21, 2023, 04:34 PM |
Deschatelets Pascal | Chief Scientific Officer | Jun 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,052,313 | Jun 09, 2023, 04:40 PM |
Deschatelets Pascal | Chief Scientific Officer | Jun 08, 2023 | Sale | $91.35 | 12,000 | 1,096,200 | 1,040,313 | Jun 09, 2023, 04:40 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Jun 05, 2023 | Option Exercise | $10.03 | 69,779 | 699,883 | 147,492 | Jun 06, 2023, 04:59 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Jun 05, 2023 | Sale | $88.80 | 69,779 | 6,196,527 | 145,892 | Jun 06, 2023, 04:59 PM |
Lewis Karen | Chief People Officer | Jun 01, 2023 | Option Exercise | $34.11 | 5,000 | 170,550 | 46,504 | Jun 02, 2023, 04:40 PM |
Lewis Karen | Chief People Officer | Jun 01, 2023 | Sale | $86.00 | 5,000 | 430,000 | 41,504 | Jun 02, 2023, 04:40 PM |
Machiels Alec | Director | May 17, 2023 | Option Exercise | $2.67 | 1,250 | 3,338 | 268,891 | May 18, 2023, 05:12 PM |
Machiels Alec | Director | May 17, 2023 | Sale | $88.66 | 1,250 | 110,825 | 267,641 | May 18, 2023, 05:12 PM |
Francois Cedric | Chief Executive Officer | May 17, 2023 | Option Exercise | $2.67 | 20,000 | 53,400 | 294,655 | May 18, 2023, 05:10 PM |
Francois Cedric | Chief Executive Officer | May 16, 2023 | Option Exercise | $2.67 | 30,000 | 80,100 | 304,655 | May 18, 2023, 05:10 PM |
Francois Cedric | Chief Executive Officer | May 16, 2023 | Sale | $85.66 | 30,000 | 2,569,900 | 303,721 | May 18, 2023, 05:10 PM |
Deschatelets Pascal | Chief Scientific Officer | May 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,045,813 | May 09, 2023, 05:02 PM |
Deschatelets Pascal | Chief Scientific Officer | May 08, 2023 | Sale | $92.39 | 12,000 | 1,108,680 | 1,033,813 | May 09, 2023, 05:02 PM |
Townsend Adam J. | Chief Commercial Officer | May 03, 2023 | Option Exercise | $15.09 | 5,000 | 75,450 | 80,995 | May 04, 2023, 04:40 PM |
Townsend Adam J. | Chief Commercial Officer | May 03, 2023 | Sale | $82.71 | 5,000 | 413,550 | 75,995 | May 04, 2023, 04:40 PM |
Francois Cedric | Chief Executive Officer | Apr 19, 2023 | Option Exercise | $2.67 | 20,000 | 53,400 | 657,601 | Apr 20, 2023, 04:51 PM |
Francois Cedric | Chief Executive Officer | Apr 18, 2023 | Option Exercise | $2.67 | 30,000 | 80,100 | 667,601 | Apr 20, 2023, 04:51 PM |
Francois Cedric | Chief Executive Officer | Apr 18, 2023 | Sale | $82.02 | 30,000 | 2,460,720 | 637,601 | Apr 20, 2023, 04:51 PM |
Machiels Alec | Director | Apr 17, 2023 | Option Exercise | $2.67 | 1,250 | 3,338 | 268,891 | Apr 18, 2023, 04:30 PM |
Machiels Alec | Director | Apr 17, 2023 | Sale | $81.05 | 1,250 | 101,313 | 267,641 | Apr 18, 2023, 04:30 PM |
Deschatelets Pascal | Chief Scientific Officer | Apr 10, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,039,313 | Apr 11, 2023, 04:20 PM |
Deschatelets Pascal | Chief Scientific Officer | Apr 10, 2023 | Sale | $78.21 | 12,000 | 938,520 | 1,027,313 | Apr 11, 2023, 04:20 PM |
Dunlop A. Sinclair | Director | Apr 03, 2023 | Sale | $74.05 | 500 | 37,025 | 131,297 | Apr 05, 2023, 04:54 PM |
Lewis Karen | Chief People Officer | Apr 03, 2023 | Option Exercise | $34.11 | 5,000 | 170,550 | 46,430 | Apr 05, 2023, 04:52 PM |
Lewis Karen | Chief People Officer | Apr 03, 2023 | Sale | $75.00 | 5,000 | 375,000 | 41,430 | Apr 05, 2023, 04:52 PM |
Townsend Adam J. | Chief Commercial Officer | Apr 03, 2023 | Option Exercise | $15.09 | 5,000 | 75,450 | 80,995 | Apr 05, 2023, 04:50 PM |
Townsend Adam J. | Chief Commercial Officer | Apr 03, 2023 | Sale | $74.05 | 5,000 | 370,250 | 75,995 | Apr 05, 2023, 04:50 PM |
Francois Cedric | Chief Executive Officer | Mar 22, 2023 | Option Exercise | $4.16 | 127,221 | 529,411 | 1,271,812 | Mar 23, 2023, 04:55 PM |
Francois Cedric | Chief Executive Officer | Mar 21, 2023 | Option Exercise | $2.67 | 30,000 | 80,100 | 1,174,591 | Mar 23, 2023, 04:55 PM |
Francois Cedric | Chief Executive Officer | Mar 21, 2023 | Sale | $62.74 | 30,000 | 1,882,332 | 1,144,591 | Mar 23, 2023, 04:55 PM |
Machiels Alec | Director | Mar 17, 2023 | Option Exercise | $2.67 | 1,250 | 3,338 | 268,891 | Mar 21, 2023, 04:35 PM |
Machiels Alec | Director | Mar 17, 2023 | Sale | $64.03 | 1,250 | 80,037 | 267,641 | Mar 21, 2023, 04:35 PM |
Deschatelets Pascal | Chief Scientific Officer | Mar 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,032,813 | Mar 10, 2023, 05:18 PM |
Deschatelets Pascal | Chief Scientific Officer | Mar 08, 2023 | Sale | $63.79 | 12,000 | 765,480 | 1,020,813 | Mar 10, 2023, 05:18 PM |
Townsend Adam J. | Chief Commercial Officer | Mar 03, 2023 | Option Exercise | $15.09 | 5,000 | 75,450 | 80,995 | Mar 07, 2023, 04:53 PM |
Townsend Adam J. | Chief Commercial Officer | Mar 03, 2023 | Sale | $63.84 | 5,000 | 319,200 | 75,995 | Mar 07, 2023, 04:53 PM |
Francois Cedric | Chief Executive Officer | Feb 27, 2023 | Option Exercise | $3.76 | 100,000 | 376,000 | 1,144,591 | Mar 01, 2023, 04:10 PM |
Eisele Jeffrey | Chief Development Officer | Feb 23, 2023 | Sale | $68.76 | 1,646 | 113,179 | 53,883 | Feb 27, 2023, 04:34 PM |
Lewis Karen | Chief People Officer | Feb 23, 2023 | Sale | $68.76 | 1,104 | 75,911 | 41,430 | Feb 27, 2023, 04:32 PM |
Lewis Karen | Chief People Officer | Feb 21, 2023 | Option Exercise | $58.50 | 553 | 32,351 | 42,534 | Feb 22, 2023, 06:50 AM |
SCHEIBLER LUKAS | Chief Research Officer | Feb 21, 2023 | Option Exercise | $58.50 | 715 | 41,828 | 69,643 | Feb 22, 2023, 06:49 AM |
DeLong Mark Jeffrey | Chief Business & Strat Officer | Feb 21, 2023 | Option Exercise | $58.50 | 441 | 25,799 | 51,341 | Feb 22, 2023, 06:46 AM |
Eisele Jeffrey | Chief Development Officer | Feb 21, 2023 | Option Exercise | $58.50 | 825 | 48,263 | 55,529 | Feb 22, 2023, 06:46 AM |
Nicholson Nur | Chief Technical Officer | Feb 21, 2023 | Option Exercise | $58.50 | 825 | 48,263 | 63,503 | Feb 22, 2023, 06:45 AM |
Chopas James George | VP/Chief Accounting Officer | Feb 21, 2023 | Option Exercise | $58.50 | 334 | 19,539 | 30,863 | Feb 22, 2023, 06:44 AM |
Deschatelets Pascal | Chief Scientific Officer | Feb 21, 2023 | Option Exercise | $58.50 | 1,195 | 69,908 | 1,014,313 | Feb 22, 2023, 06:44 AM |
Sullivan Timothy Eugene | Chief Financial Officer | Feb 21, 2023 | Option Exercise | $58.50 | 974 | 56,979 | 133,945 | Feb 22, 2023, 06:42 AM |
Watson David O. | General Counsel | Feb 21, 2023 | Option Exercise | $58.50 | 825 | 48,263 | 174,968 | Feb 22, 2023, 06:42 AM |
Francois Cedric | Chief Executive Officer | Feb 21, 2023 | Option Exercise | $58.50 | 1,602 | 93,717 | 1,044,591 | Feb 22, 2023, 06:40 AM |
Townsend Adam J. | Chief Commercial Officer | Feb 21, 2023 | Option Exercise | $58.50 | 1,041 | 60,899 | 75,995 | Feb 22, 2023, 06:36 AM |
Machiels Alec | Director | Feb 17, 2023 | Option Exercise | $2.67 | 1,250 | 3,338 | 268,891 | Feb 21, 2023, 04:22 PM |
Machiels Alec | Director | Feb 17, 2023 | Sale | $52.38 | 1,250 | 65,475 | 267,641 | Feb 21, 2023, 04:22 PM |
Watson David O. | General Counsel | Feb 10, 2023 | Option Exercise | $51.21 | 532 | 27,244 | 165,907 | Feb 14, 2023, 05:29 PM |
Townsend Adam J. | Chief Commercial Officer | Feb 10, 2023 | Option Exercise | $51.21 | 782 | 40,046 | 67,150 | Feb 14, 2023, 05:03 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Feb 10, 2023 | Option Exercise | $51.21 | 975 | 49,930 | 123,236 | Feb 14, 2023, 04:59 PM |
SCHEIBLER LUKAS | Chief Research Officer | Feb 10, 2023 | Option Exercise | $51.21 | 678 | 34,720 | 60,472 | Feb 14, 2023, 04:44 PM |
Francois Cedric | Chief Executive Officer | Feb 10, 2023 | Option Exercise | $51.21 | 3,958 | 202,689 | 1,032,285 | Feb 14, 2023, 04:42 PM |
Deschatelets Pascal | Chief Scientific Officer | Feb 10, 2023 | Option Exercise | $51.21 | 1,134 | 58,072 | 1,005,622 | Feb 14, 2023, 04:28 PM |
DeLong Mark Jeffrey | Chief Business & Strat Officer | Feb 10, 2023 | Option Exercise | $51.21 | 670 | 34,311 | 46,502 | Feb 14, 2023, 04:24 PM |
Deschatelets Pascal | Chief Scientific Officer | Feb 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,018,756 | Feb 10, 2023, 05:00 PM |
Deschatelets Pascal | Chief Scientific Officer | Feb 08, 2023 | Sale | $54.45 | 12,000 | 653,400 | 1,006,756 | Feb 10, 2023, 05:00 PM |
Townsend Adam J. | Chief Commercial Officer | Feb 03, 2023 | Option Exercise | $15.09 | 5,000 | 75,450 | 72,932 | Feb 06, 2023, 05:35 PM |
Townsend Adam J. | Chief Commercial Officer | Feb 03, 2023 | Sale | $55.85 | 5,000 | 279,250 | 67,932 | Feb 06, 2023, 05:35 PM |
Dunlop A. Sinclair | Director | Feb 01, 2023 | Sale | $52.61 | 500 | 26,305 | 132,297 | Feb 02, 2023, 04:15 PM |
Eisele Jeffrey | Chief Development Officer | Jan 30, 2023 | Sale | $52.76 | 883 | 46,587 | 46,468 | Jan 31, 2023, 04:51 PM |
Lewis Karen | Chief People Officer | Jan 30, 2023 | Sale | $52.76 | 883 | 46,587 | 36,459 | Jan 31, 2023, 04:47 PM |
Watson David O. | General Counsel | Jan 27, 2023 | Option Exercise | $52.77 | 551 | 29,076 | 166,439 | Jan 30, 2023, 05:19 PM |
Townsend Adam J. | Chief Commercial Officer | Jan 27, 2023 | Option Exercise | $52.77 | 551 | 29,076 | 67,932 | Jan 30, 2023, 05:07 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Jan 27, 2023 | Option Exercise | $52.77 | 551 | 29,076 | 124,211 | Jan 30, 2023, 05:05 PM |
SCHEIBLER LUKAS | Chief Research Officer | Jan 27, 2023 | Option Exercise | $52.77 | 542 | 28,601 | 61,150 | Jan 30, 2023, 05:03 PM |
Nicholson Nur | Chief Technical Officer | Jan 27, 2023 | Option Exercise | $52.77 | 551 | 29,076 | 54,442 | Jan 30, 2023, 05:02 PM |
Lewis Karen | Chief People Officer | Jan 27, 2023 | Option Exercise | $52.77 | 367 | 19,367 | 37,342 | Jan 30, 2023, 05:01 PM |
Francois Cedric | Chief Executive Officer | Jan 27, 2023 | Option Exercise | $52.77 | 2,879 | 151,925 | 1,036,243 | Jan 30, 2023, 04:59 PM |
Eisele Jeffrey | Chief Development Officer | Jan 27, 2023 | Option Exercise | $52.77 | 367 | 19,367 | 47,351 | Jan 30, 2023, 04:58 PM |
Deschatelets Pascal | Chief Scientific Officer | Jan 27, 2023 | Option Exercise | $52.77 | 832 | 43,905 | 1,000,256 | Jan 30, 2023, 04:47 PM |
DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 27, 2023 | Option Exercise | $52.77 | 367 | 19,367 | 47,172 | Jan 30, 2023, 04:45 PM |
Lewis Karen | Chief People Officer | Jan 23, 2023 | Sale | $51.58 | 2,955 | 152,419 | 37,709 | Jan 25, 2023, 04:17 PM |
Eisele Jeffrey | Chief Development Officer | Jan 23, 2023 | Sale | $51.58 | 4,479 | 231,027 | 47,718 | Jan 25, 2023, 04:14 PM |
Watson David O. | General Counsel | Jan 20, 2023 | Option Exercise | $52.05 | 2,034 | 105,870 | 166,990 | Jan 24, 2023, 05:33 PM |
Townsend Adam J. | Chief Commercial Officer | Jan 20, 2023 | Option Exercise | $52.05 | 1,912 | 99,520 | 68,483 | Jan 24, 2023, 05:32 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Jan 20, 2023 | Option Exercise | $52.05 | 2,379 | 123,827 | 124,762 | Jan 24, 2023, 05:23 PM |
SCHEIBLER LUKAS | Chief Research Officer | Jan 20, 2023 | Option Exercise | $52.05 | 2,015 | 104,881 | 61,692 | Jan 24, 2023, 05:22 PM |
Nicholson Nur | Chief Technical Officer | Jan 20, 2023 | Option Exercise | $52.05 | 2,034 | 105,870 | 54,993 | Jan 24, 2023, 05:21 PM |
Lewis Karen | Chief People Officer | Jan 20, 2023 | Option Exercise | $52.05 | 1,411 | 73,443 | 40,664 | Jan 24, 2023, 05:20 PM |
Francois Cedric | Chief Executive Officer | Jan 20, 2023 | Option Exercise | $52.05 | 9,453 | 492,029 | 1,039,122 | Jan 24, 2023, 05:17 PM |
Eisele Jeffrey | Chief Development Officer | Jan 20, 2023 | Option Exercise | $52.05 | 2,033 | 105,818 | 52,197 | Jan 24, 2023, 05:15 PM |
Deschatelets Pascal | Chief Scientific Officer | Jan 20, 2023 | Option Exercise | $52.05 | 2,326 | 121,068 | 1,001,088 | Jan 24, 2023, 05:14 PM |
DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 20, 2023 | Option Exercise | $52.05 | 1,149 | 59,805 | 47,539 | Jan 24, 2023, 05:12 PM |
Chopas James George | VP/Chief Accounting Officer | Jan 20, 2023 | Option Exercise | $52.05 | 919 | 47,834 | 27,153 | Jan 24, 2023, 04:58 PM |
Brown Victoria L. | Program Team Lead | Jan 20, 2023 | Option Exercise | $52.05 | 1,412 | 73,495 | 23,556 | Jan 24, 2023, 04:57 PM |
Machiels Alec | Director | Jan 17, 2023 | Option Exercise | $2.67 | 1,250 | 3,338 | 268,891 | Jan 19, 2023, 04:55 PM |
Machiels Alec | Director | Jan 17, 2023 | Sale | $52.42 | 1,250 | 65,525 | 267,641 | Jan 19, 2023, 04:55 PM |
Deschatelets Pascal | Chief Scientific Officer | Jan 09, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 995,780 | Jan 10, 2023, 08:07 PM |
Deschatelets Pascal | Chief Scientific Officer | Jan 09, 2023 | Sale | $46.08 | 12,000 | 552,960 | 983,780 | Jan 10, 2023, 08:07 PM |
Grossi Federico | Chief Medical Officer | Jan 05, 2023 | Sale | $48.79 | 2,500 | 121,975 | 94,884 | Jan 09, 2023, 07:02 PM |
Townsend Adam J. | Chief Commercial Officer | Jan 03, 2023 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Jan 05, 2023, 08:00 PM |
Townsend Adam J. | Chief Commercial Officer | Jan 03, 2023 | Sale | $50.70 | 5,000 | 253,500 | 42,907 | Jan 05, 2023, 08:00 PM |
Dunlop A. Sinclair | Director | Jan 03, 2023 | Sale | $50.70 | 500 | 25,350 | 132,797 | Jan 05, 2023, 07:40 PM |
Deschatelets Pascal | Chief Scientific Officer | Dec 29, 2022 | Option Exercise | $3.67 | 7,000 | 25,690 | 977,280 | Dec 30, 2022, 05:00 PM |
Eisele Jeffrey | Exec VP, Program Team Lead | Dec 22, 2022 | Option Exercise | $51.68 | 89 | 4,600 | 31,650 | Dec 23, 2022, 04:15 PM |
Francois Cedric | Chief Executive Officer | Dec 19, 2022 | Option Exercise | $4.64 | 49,888 | 231,680 | 993,328 | Dec 21, 2022, 04:13 PM |
Francois Cedric | Chief Executive Officer | Dec 19, 2022 | Sale | $52.06 | 28,200 | 1,467,983 | 989,577 | Dec 21, 2022, 04:13 PM |
Machiels Alec | Director | Dec 15, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 265,024 | Dec 19, 2022, 04:37 PM |
Machiels Alec | Director | Dec 15, 2022 | Sale | $52.35 | 1,250 | 65,437 | 263,774 | Dec 19, 2022, 04:37 PM |
Deschatelets Pascal | Chief Scientific Officer | Dec 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 982,280 | Dec 12, 2022, 04:28 PM |
Deschatelets Pascal | Chief Scientific Officer | Dec 08, 2022 | Sale | $47.50 | 12,000 | 570,000 | 970,280 | Dec 12, 2022, 04:28 PM |
Townsend Adam J. | Chief Commercial Officer | Dec 05, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Dec 07, 2022, 08:30 AM |
Townsend Adam J. | Chief Commercial Officer | Dec 05, 2022 | Sale | $50.38 | 5,000 | 251,900 | 42,907 | Dec 07, 2022, 08:30 AM |
Dunlop A. Sinclair | Director | Dec 01, 2022 | Sale | $49.93 | 500 | 24,965 | 129,430 | Dec 02, 2022, 04:30 PM |
Grossi Federico | Chief Medical Officer | Dec 01, 2022 | Sale | $49.93 | 2,500 | 124,825 | 97,384 | Dec 02, 2022, 04:30 PM |
Machiels Alec | Director | Nov 15, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 265,024 | Nov 17, 2022, 04:33 PM |
Machiels Alec | Director | Nov 15, 2022 | Sale | $48.01 | 1,250 | 60,012 | 263,774 | Nov 17, 2022, 04:33 PM |
Deschatelets Pascal | Chief Scientific Officer | Nov 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 975,780 | Nov 10, 2022, 08:30 AM |
Deschatelets Pascal | Chief Scientific Officer | Nov 08, 2022 | Sale | $46.47 | 12,000 | 557,640 | 963,780 | Nov 10, 2022, 08:30 AM |
Townsend Adam J. | Chief Commercial Officer | Nov 03, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Nov 07, 2022, 04:19 PM |
Townsend Adam J. | Chief Commercial Officer | Nov 03, 2022 | Sale | $58.54 | 5,000 | 292,700 | 42,907 | Nov 07, 2022, 04:19 PM |
Dunlop A. Sinclair | Director | Nov 01, 2022 | Sale | $60.83 | 500 | 30,415 | 129,930 | Nov 03, 2022, 04:28 PM |
Grossi Federico | Chief Medical Officer | Nov 01, 2022 | Sale | $60.83 | 2,500 | 152,075 | 99,884 | Nov 03, 2022, 04:27 PM |
Brown Victoria L. | Program Team Lead | Oct 26, 2022 | Option Exercise | $58.41 | 130 | 7,593 | 24,844 | Oct 28, 2022, 04:20 PM |
DeLong Mark Jeffrey | Senior Vice President | Oct 20, 2022 | Option Exercise | $58.00 | 196 | 11,368 | 29,054 | Oct 24, 2022, 05:10 PM |
Chopas James George | VP/Chief Accounting Officer | Oct 20, 2022 | Option Exercise | $58.00 | 130 | 7,540 | 18,451 | Oct 24, 2022, 05:09 PM |
Machiels Alec | Director | Oct 14, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 265,024 | Oct 17, 2022, 05:57 PM |
Machiels Alec | Director | Oct 14, 2022 | Sale | $59.31 | 1,250 | 74,138 | 263,774 | Oct 17, 2022, 05:57 PM |
Deschatelets Pascal | Chief Scientific Officer | Oct 10, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 969,280 | Oct 11, 2022, 04:58 PM |
Deschatelets Pascal | Chief Scientific Officer | Oct 10, 2022 | Sale | $57.50 | 12,000 | 690,000 | 957,280 | Oct 11, 2022, 04:58 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Oct 03, 2022 | Sale | $66.69 | 2,500 | 166,725 | 102,384 | Oct 05, 2022, 05:14 PM |
Townsend Adam J. | Chief Commercial Officer | Oct 03, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Oct 05, 2022, 05:12 PM |
Townsend Adam J. | Chief Commercial Officer | Oct 03, 2022 | Sale | $66.69 | 5,000 | 333,450 | 42,907 | Oct 05, 2022, 05:12 PM |
Machiels Alec | Director | Sep 15, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 265,024 | Sep 16, 2022, 04:03 PM |
Machiels Alec | Director | Sep 15, 2022 | Sale | $66.00 | 1,250 | 82,500 | 263,774 | Sep 16, 2022, 04:03 PM |
Deschatelets Pascal | Chief Scientific Officer | Sep 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 962,780 | Sep 12, 2022, 04:52 PM |
Deschatelets Pascal | Chief Scientific Officer | Sep 08, 2022 | Sale | $63.98 | 12,000 | 767,760 | 950,780 | Sep 12, 2022, 04:52 PM |
Dunlop A. Sinclair | Director | Sep 08, 2022 | Sale | $65.00 | 15,000 | 975,000 | 240,679 | Sep 08, 2022, 04:38 PM |
Townsend Adam J. | Chief Commercial Officer | Sep 06, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Sep 07, 2022, 04:37 PM |
Townsend Adam J. | Chief Commercial Officer | Sep 06, 2022 | Sale | $60.38 | 5,000 | 301,900 | 42,907 | Sep 07, 2022, 04:37 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Sep 01, 2022 | Sale | $60.30 | 2,500 | 150,750 | 104,884 | Sep 02, 2022, 04:22 PM |
Chopas James George | VP/Chief Accounting Officer | Aug 30, 2022 | Option Exercise | $58.84 | 558 | 32,833 | 18,581 | Aug 31, 2022, 04:26 PM |
Dunlop A. Sinclair | Director | Aug 25, 2022 | Option Exercise | $13.19 | 4,306 | 56,796 | 130,430 | Aug 26, 2022, 04:06 PM |
DeLong Mark Jeffrey | Senior Vice President | Aug 17, 2022 | Option Exercise | $15.52 | 5,000 | 77,600 | 34,250 | Aug 18, 2022, 04:02 PM |
DeLong Mark Jeffrey | Senior Vice President | Aug 17, 2022 | Sale | $69.50 | 5,000 | 347,500 | 29,250 | Aug 18, 2022, 04:02 PM |
Dunlop A. Sinclair | Director | Aug 16, 2022 | Option Exercise | $14.00 | 25,394 | 355,516 | 126,124 | Aug 17, 2022, 05:08 PM |
Townsend Adam J. | Chief Commercial Officer | Aug 15, 2022 | Option Exercise | $15.09 | 12,500 | 188,625 | 55,407 | Aug 16, 2022, 05:04 PM |
Townsend Adam J. | Chief Commercial Officer | Aug 15, 2022 | Sale | $69.00 | 12,500 | 862,500 | 42,907 | Aug 16, 2022, 05:04 PM |
Machiels Alec | Director | Aug 15, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 265,024 | Aug 16, 2022, 05:00 PM |
Machiels Alec | Director | Aug 15, 2022 | Sale | $67.21 | 1,250 | 84,012 | 263,774 | Aug 16, 2022, 05:00 PM |
Townsend Adam J. | Chief Commercial Officer | Aug 11, 2022 | Option Exercise | $15.09 | 12,500 | 188,625 | 55,407 | Aug 12, 2022, 05:01 PM |
Townsend Adam J. | Chief Commercial Officer | Aug 11, 2022 | Sale | $67.00 | 12,500 | 837,500 | 42,907 | Aug 12, 2022, 05:01 PM |
DeLong Mark Jeffrey | Senior Vice President | Aug 11, 2022 | Option Exercise | $15.52 | 5,000 | 77,600 | 34,250 | Aug 12, 2022, 04:58 PM |
DeLong Mark Jeffrey | Senior Vice President | Aug 11, 2022 | Sale | $67.00 | 5,000 | 335,000 | 29,250 | Aug 12, 2022, 04:58 PM |
Dunlop A. Sinclair | Director | Aug 11, 2022 | Sale | $65.63 | 30,000 | 1,968,900 | 255,679 | Aug 12, 2022, 04:57 PM |
Townsend Adam J. | Chief Commercial Officer | Aug 08, 2022 | Option Exercise | $15.09 | 12,500 | 188,625 | 55,407 | Aug 09, 2022, 05:22 PM |
Townsend Adam J. | Chief Commercial Officer | Aug 08, 2022 | Sale | $65.00 | 12,500 | 812,500 | 42,907 | Aug 09, 2022, 05:22 PM |
Deschatelets Pascal | Chief Scientific Officer | Aug 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 956,280 | Aug 09, 2022, 05:18 PM |
Deschatelets Pascal | Chief Scientific Officer | Aug 08, 2022 | Sale | $62.50 | 12,000 | 750,000 | 944,280 | Aug 09, 2022, 05:18 PM |
DeLong Mark Jeffrey | Senior Vice President | Aug 08, 2022 | Option Exercise | $15.52 | 5,000 | 77,600 | 34,250 | Aug 09, 2022, 05:16 PM |
DeLong Mark Jeffrey | Senior Vice President | Aug 08, 2022 | Sale | $64.50 | 5,000 | 322,500 | 29,250 | Aug 09, 2022, 05:16 PM |
DeLong Mark Jeffrey | Senior Vice President | Aug 04, 2022 | Option Exercise | $15.52 | 10,000 | 155,200 | 39,250 | Aug 08, 2022, 04:02 PM |
DeLong Mark Jeffrey | Senior Vice President | Aug 04, 2022 | Sale | $60.75 | 10,000 | 607,500 | 34,250 | Aug 08, 2022, 04:02 PM |
Townsend Adam J. | Chief Commercial Officer | Aug 03, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 42,907 | Aug 04, 2022, 06:40 PM |
Townsend Adam J. | Chief Commercial Officer | Aug 03, 2022 | Sale | $56.43 | 5,000 | 282,150 | 37,907 | Aug 04, 2022, 06:40 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Aug 01, 2022 | Sale | $55.99 | 2,500 | 139,975 | 107,384 | Aug 02, 2022, 04:18 PM |
DeLong Mark Jeffrey | Senior Vice President | Jul 27, 2022 | Option Exercise | $15.52 | 5,000 | 77,600 | 34,250 | Jul 28, 2022, 04:03 PM |
DeLong Mark Jeffrey | Senior Vice President | Jul 27, 2022 | Sale | $57.00 | 5,000 | 285,000 | 29,250 | Jul 28, 2022, 04:03 PM |
Dunlop A. Sinclair | Director | Jul 21, 2022 | Option Exercise | $14.00 | 9,606 | 134,484 | 100,730 | Jul 22, 2022, 04:01 PM |
DeLong Mark Jeffrey | Senior Vice President | Jul 19, 2022 | Option Exercise | $15.52 | 5,000 | 77,600 | 34,250 | Jul 21, 2022, 04:31 PM |
DeLong Mark Jeffrey | Senior Vice President | Jul 19, 2022 | Sale | $56.42 | 5,000 | 282,100 | 29,250 | Jul 21, 2022, 04:31 PM |
Machiels Alec | Director | Jul 15, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 265,024 | Jul 18, 2022, 05:29 PM |
Machiels Alec | Director | Jul 15, 2022 | Sale | $46.33 | 1,250 | 57,913 | 263,774 | Jul 18, 2022, 05:29 PM |
Townsend Adam J. | Chief Commercial Officer | Jul 11, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Jul 12, 2022, 05:55 PM |
Townsend Adam J. | Chief Commercial Officer | Jul 11, 2022 | Sale | $48.42 | 5,000 | 242,100 | 42,907 | Jul 12, 2022, 05:55 PM |
Deschatelets Pascal | Chief Scientific Officer | Jul 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 949,780 | Jul 12, 2022, 04:04 PM |
Deschatelets Pascal | Chief Scientific Officer | Jul 08, 2022 | Sale | $47.95 | 12,000 | 575,400 | 937,780 | Jul 12, 2022, 04:04 PM |
Dunlop A. Sinclair | Director | Jun 27, 2022 | Sale | $46.79 | 1,341 | 62,743 | 1,341 | Jun 29, 2022, 04:18 PM |
Dunlop A. Sinclair | Director | Jun 23, 2022 | Sale | $45.00 | 15,000 | 675,000 | 285,679 | Jun 24, 2022, 05:15 PM |
Watson David O. | General Counsel | Jun 22, 2022 | Sale | $44.51 | 10,000 | 445,140 | 115,569 | Jun 23, 2022, 04:22 PM |
Deschatelets Pascal | Chief Scientific Officer | Jun 17, 2022 | Option Exercise | $2.67 | 33,005 | 88,123 | 931,280 | Jun 22, 2022, 04:32 PM |
Brown Victoria L. | Program Team Lead | Jun 17, 2022 | Sale | $45.00 | 2,698 | 121,410 | 24,974 | Jun 22, 2022, 04:26 PM |
DeLong Mark Jeffrey | Senior Vice President | Jun 16, 2022 | Option Exercise | $13.85 | 10,000 | 138,500 | 39,250 | Jun 21, 2022, 04:11 PM |
DeLong Mark Jeffrey | Senior Vice President | Jun 16, 2022 | Sale | $41.78 | 10,000 | 417,850 | 29,250 | Jun 21, 2022, 04:11 PM |
Machiels Alec | Director | Jun 15, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 265,024 | Jun 17, 2022, 05:02 PM |
Machiels Alec | Director | Jun 15, 2022 | Sale | $39.29 | 1,250 | 49,113 | 263,774 | Jun 17, 2022, 05:02 PM |
Deschatelets Pascal | Chief Scientific Officer | Jun 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 903,775 | Jun 09, 2022, 05:23 PM |
Deschatelets Pascal | Chief Scientific Officer | Jun 08, 2022 | Sale | $44.09 | 12,000 | 529,080 | 891,775 | Jun 09, 2022, 05:23 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jun 01, 2022 | Sale | $41.78 | 2,500 | 104,450 | 109,561 | Jun 02, 2022, 06:24 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | May 27, 2022 | Sale | $43.00 | 10,000 | 430,000 | 40,358 | May 31, 2022, 04:30 PM |
Machiels Alec | Director | May 16, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 265,024 | May 17, 2022, 05:26 PM |
Machiels Alec | Director | May 16, 2022 | Sale | $39.18 | 1,250 | 48,975 | 263,774 | May 17, 2022, 05:26 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | May 02, 2022 | Sale | $43.56 | 2,500 | 108,900 | 112,061 | May 03, 2022, 07:56 PM |
Deschatelets Pascal | Chief Scientific Officer | Apr 29, 2022 | Option Exercise | $2.67 | 4,000 | 10,680 | 895,775 | May 02, 2022, 08:05 PM |
Deschatelets Pascal | Chief Scientific Officer | Apr 29, 2022 | Sale | $44.43 | 4,000 | 177,720 | 891,775 | May 02, 2022, 08:05 PM |
Watson David O. | General Counsel | Apr 25, 2022 | Sale | $50.00 | 5,000 | 250,000 | 125,569 | Apr 27, 2022, 04:39 PM |
Dunlop A. Sinclair | Director | Apr 22, 2022 | Option Exercise | $14.00 | 20,000 | 280,000 | 91,124 | Apr 25, 2022, 09:35 PM |
DeLong Mark Jeffrey | Senior Vice President | Apr 20, 2022 | Option Exercise | $15.52 | 7,000 | 108,640 | 35,481 | Apr 22, 2022, 05:35 PM |
DeLong Mark Jeffrey | Senior Vice President | Apr 20, 2022 | Sale | $52.53 | 7,000 | 367,710 | 28,481 | Apr 22, 2022, 05:35 PM |
Machiels Alec | Director | Apr 14, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 265,024 | Apr 18, 2022, 07:42 PM |
Machiels Alec | Director | Apr 14, 2022 | Sale | $50.90 | 1,250 | 63,625 | 263,774 | Apr 18, 2022, 07:42 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Apr 05, 2022 | Option Exercise | $13.85 | 609 | 8,435 | 52,842 | Apr 06, 2022, 04:10 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Apr 05, 2022 | Sale | $60.09 | 609 | 36,593 | 52,233 | Apr 06, 2022, 04:10 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Apr 04, 2022 | Option Exercise | $13.85 | 3,504 | 48,530 | 55,737 | Apr 05, 2022, 04:08 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Apr 04, 2022 | Sale | $56.96 | 3,504 | 199,589 | 54,919 | Apr 05, 2022, 04:08 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Apr 01, 2022 | Option Exercise | $13.85 | 11,496 | 159,220 | 63,729 | Apr 04, 2022, 05:03 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Apr 01, 2022 | Sale | $55.05 | 11,496 | 632,855 | 52,233 | Apr 04, 2022, 05:03 PM |
Brown Victoria L. | Program Team Lead | Mar 25, 2022 | Option Exercise | $49.28 | 82 | 4,041 | 28,325 | Mar 29, 2022, 04:12 PM |
Machiels Alec | Director | Mar 15, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 260,794 | Mar 17, 2022, 08:59 PM |
Machiels Alec | Director | Mar 15, 2022 | Sale | $39.57 | 1,250 | 49,462 | 259,544 | Mar 17, 2022, 08:59 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Mar 15, 2022 | Option Exercise | $4.31 | 7,000 | 30,170 | 116,811 | Mar 17, 2022, 06:19 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Mar 15, 2022 | Sale | $39.57 | 375 | 14,839 | 116,436 | Mar 17, 2022, 06:19 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Mar 01, 2022 | Sale | $43.53 | 375 | 16,324 | 109,811 | Mar 02, 2022, 06:15 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Feb 23, 2022 | Option Exercise | $4.31 | 4,100 | 17,671 | 110,186 | Feb 24, 2022, 04:33 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Feb 15, 2022 | Sale | $45.43 | 375 | 17,036 | 106,086 | Feb 16, 2022, 04:29 PM |
Machiels Alec | Director | Feb 15, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 675,024 | Feb 16, 2022, 04:29 PM |
Machiels Alec | Director | Feb 15, 2022 | Sale | $45.43 | 1,250 | 56,788 | 673,774 | Feb 16, 2022, 04:29 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Feb 14, 2022 | Option Exercise | $4.31 | 3,600 | 15,516 | 106,461 | Feb 15, 2022, 04:59 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Feb 14, 2022 | Option Exercise | $26.73 | 720 | 19,246 | 52,233 | Feb 15, 2022, 04:58 PM |
Watson David O. | General Counsel | Feb 10, 2022 | Option Exercise | $47.12 | 491 | 23,136 | 132,444 | Feb 14, 2022, 06:36 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Feb 10, 2022 | Option Exercise | $47.12 | 705 | 33,220 | 102,861 | Feb 14, 2022, 04:29 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Feb 08, 2022 | Option Exercise | $13.85 | 10,000 | 138,500 | 63,857 | Feb 10, 2022, 08:32 AM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Feb 08, 2022 | Sale | $45.00 | 10,000 | 450,000 | 53,857 | Feb 10, 2022, 08:32 AM |
Grossi Federico | CHIEF MEDICAL OFFICER | Feb 01, 2022 | Sale | $40.58 | 375 | 15,218 | 103,566 | Feb 02, 2022, 04:50 PM |
Brown Victoria L. | Program Team Lead | Jan 28, 2022 | Option Exercise | $38.59 | 434 | 16,748 | 28,582 | Feb 01, 2022, 06:11 PM |
DeLong Mark Jeffrey | Senior Vice President | Jan 28, 2022 | Option Exercise | $38.59 | 434 | 16,748 | 20,530 | Feb 01, 2022, 06:10 PM |
Eisele Jeffrey | Exec VP, Program Team Lead | Jan 28, 2022 | Option Exercise | $38.59 | 434 | 16,748 | 32,989 | Feb 01, 2022, 06:09 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jan 28, 2022 | Option Exercise | $38.59 | 650 | 25,084 | 103,941 | Feb 01, 2022, 06:07 PM |
Nicholson Nur | Chief Technical Officer | Jan 28, 2022 | Option Exercise | $38.59 | 650 | 25,084 | 35,555 | Feb 01, 2022, 06:06 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Jan 28, 2022 | Option Exercise | $38.59 | 650 | 25,084 | 104,278 | Feb 01, 2022, 06:05 PM |
Watson David O. | General Counsel | Jan 28, 2022 | Option Exercise | $38.59 | 650 | 25,084 | 132,935 | Feb 01, 2022, 06:03 PM |
Townsend Adam J. | Chief Commercial Officer | Jan 28, 2022 | Option Exercise | $38.59 | 800 | 30,872 | 44,908 | Feb 01, 2022, 06:01 PM |
Deschatelets Pascal | Chief Scientific Officer | Jan 28, 2022 | Option Exercise | $38.59 | 931 | 35,927 | 894,707 | Feb 01, 2022, 06:00 PM |
Francois Cedric | Chief Executive Officer | Jan 28, 2022 | Option Exercise | $38.59 | 2,024 | 78,106 | 1,338,463 | Feb 01, 2022, 06:00 PM |
Lewis Karen | Chief People Officer | Jan 28, 2022 | Option Exercise | $38.59 | 434 | 16,748 | 23,474 | Feb 01, 2022, 05:59 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Jan 28, 2022 | Option Exercise | $38.59 | 642 | 24,775 | 55,090 | Feb 01, 2022, 05:58 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Jan 31, 2022 | Sale | $38.47 | 1,233 | 47,434 | 53,857 | Feb 01, 2022, 05:58 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Jan 21, 2022 | Option Exercise | $26.73 | 3,021 | 80,751 | 29,681 | Jan 24, 2022, 05:26 PM |
Machiels Alec | Director | Jan 14, 2022 | Option Exercise | $2.67 | 1,250 | 3,338 | 675,024 | Jan 19, 2022, 08:15 PM |
Machiels Alec | Director | Jan 14, 2022 | Sale | $40.56 | 1,250 | 50,700 | 673,774 | Jan 19, 2022, 08:15 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jan 14, 2022 | Option Exercise | $4.31 | 3,400 | 14,654 | 78,915 | Jan 19, 2022, 08:03 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jan 14, 2022 | Sale | $40.56 | 375 | 15,210 | 78,540 | Jan 19, 2022, 08:03 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jan 12, 2022 | Option Exercise | $3.92 | 5,161 | 20,230 | 75,515 | Jan 14, 2022, 04:57 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jan 03, 2022 | Sale | $47.31 | 375 | 17,741 | 70,354 | Jan 04, 2022, 04:07 PM |
Watson David O. | General Counsel | Dec 27, 2021 | Sale | $48.50 | 1,200 | 58,200 | 107,534 | Dec 28, 2021, 05:38 PM |
Watson David O. | General Counsel | Dec 22, 2021 | Option Exercise | $14.40 | 20,112 | 289,674 | 114,131 | Dec 23, 2021, 04:58 PM |
Watson David O. | General Counsel | Dec 22, 2021 | Sale | $47.81 | 10,571 | 505,373 | 109,034 | Dec 23, 2021, 04:58 PM |
Eisele Jeffrey | Exec VP, Program Team Lead | Dec 22, 2021 | Option Exercise | $47.82 | 89 | 4,256 | 7,372 | Dec 23, 2021, 04:49 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Dec 15, 2021 | Sale | $42.88 | 375 | 16,080 | 70,729 | Dec 17, 2021, 05:10 PM |
Machiels Alec | Director | Dec 15, 2021 | Option Exercise | $2.67 | 3,000 | 8,010 | 672,544 | Dec 17, 2021, 05:09 PM |
Machiels Alec | Director | Dec 15, 2021 | Sale | $42.88 | 3,000 | 128,640 | 669,544 | Dec 17, 2021, 05:09 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Dec 08, 2021 | Option Exercise | $3.76 | 7,000 | 26,320 | 71,104 | Dec 09, 2021, 04:57 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Dec 01, 2021 | Sale | $42.40 | 375 | 15,900 | 64,104 | Dec 03, 2021, 04:00 PM |
Morningside Venture Investments Ltd | 10% Owner | Nov 18, 2021 | Buy | $40.00 | 250,000 | 10,000,000 | 12,806,342 | Nov 18, 2021, 04:16 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Nov 15, 2021 | Sale | $43.50 | 625 | 27,188 | 64,479 | Nov 17, 2021, 05:02 PM |
Machiels Alec | Director | Nov 04, 2021 | Option Exercise | $2.67 | 3,000 | 8,010 | 672,544 | Nov 17, 2021, 05:01 PM |
Machiels Alec | Director | Nov 15, 2021 | Option Exercise | $2.67 | 3,000 | 8,010 | 672,544 | Nov 17, 2021, 05:01 PM |
Machiels Alec | Director | Nov 04, 2021 | Sale | $35.00 | 3,000 | 105,000 | 669,544 | Nov 17, 2021, 05:01 PM |
Machiels Alec | Director | Nov 15, 2021 | Sale | $43.50 | 3,000 | 130,500 | 669,544 | Nov 17, 2021, 05:01 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Nov 01, 2021 | Sale | $30.70 | 625 | 19,188 | 64,805 | Nov 02, 2021, 04:01 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Oct 14, 2021 | Sale | $34.57 | 750 | 25,927 | 65,430 | Oct 15, 2021, 04:02 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Oct 01, 2021 | Sale | $33.26 | 750 | 24,945 | 66,180 | Oct 05, 2021, 04:16 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Sep 28, 2021 | Option Exercise | $3.76 | 4,000 | 15,040 | 66,930 | Sep 29, 2021, 09:48 PM |
Dunlop A. Sinclair | Director | Sep 10, 2021 | Option Exercise | $14.00 | 6,894 | 96,516 | 66,894 | Sep 13, 2021, 04:10 PM |
Watson David O. | General Counsel | Sep 10, 2021 | Option Exercise | $4.31 | 954 | 4,112 | 99,193 | Sep 13, 2021, 04:08 PM |
Machiels Alec | Director | Aug 16, 2021 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Aug 17, 2021, 04:42 PM |
Machiels Alec | Director | Aug 16, 2021 | Sale | $56.95 | 2,500 | 142,375 | 669,544 | Aug 17, 2021, 04:42 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Aug 02, 2021 | Sale | $63.99 | 250 | 15,998 | 62,930 | Aug 03, 2021, 04:26 PM |
Perry Nicole D | Vice President - Accounting | Aug 02, 2021 | Option Exercise | $3.76 | 1,000 | 3,760 | 5,847 | Aug 03, 2021, 04:23 PM |
Perry Nicole D | Vice President - Accounting | Aug 02, 2021 | Sale | $63.99 | 1,000 | 63,990 | 4,847 | Aug 03, 2021, 04:23 PM |
DeLong Mark Jeffrey | Senior Vice President | Jul 21, 2021 | Option Exercise | $15.52 | 1,000 | 15,520 | 10,490 | Jul 22, 2021, 04:24 PM |
DeLong Mark Jeffrey | Senior Vice President | Jul 21, 2021 | Sale | $65.00 | 1,000 | 65,000 | 9,490 | Jul 22, 2021, 04:24 PM |
Francois Cedric | Chief Executive Officer | Jul 21, 2021 | Option Exercise | $4.31 | 14,410 | 62,107 | 1,234,243 | Jul 22, 2021, 04:04 PM |
DeLong Mark Jeffrey | Senior Vice President | Jul 15, 2021 | Option Exercise | $15.52 | 1,000 | 15,520 | 10,490 | Jul 16, 2021, 06:40 PM |
DeLong Mark Jeffrey | Senior Vice President | Jul 15, 2021 | Sale | $62.30 | 1,000 | 62,300 | 9,490 | Jul 16, 2021, 06:40 PM |
Machiels Alec | Director | Jul 15, 2021 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Jul 16, 2021, 06:38 PM |
Machiels Alec | Director | Jul 15, 2021 | Sale | $62.30 | 2,500 | 155,750 | 669,544 | Jul 16, 2021, 06:38 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jul 14, 2021 | Sale | $64.68 | 500 | 32,340 | 63,180 | Jul 15, 2021, 04:56 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jul 08, 2021 | Sale | $65.68 | 250 | 16,420 | 63,680 | Jul 09, 2021, 03:59 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jun 28, 2021 | Option Exercise | $3.76 | 9,000 | 33,840 | 63,930 | Jun 29, 2021, 04:58 PM |
Deschatelets Pascal | Chief Scientific Officer | Jun 24, 2021 | Option Exercise | $2.67 | 6,250 | 16,688 | 875,837 | Jun 25, 2021, 09:48 PM |
Deschatelets Pascal | Chief Scientific Officer | Jun 24, 2021 | Sale | $65.61 | 6,250 | 410,063 | 869,587 | Jun 25, 2021, 09:48 PM |
Machiels Alec | Director | Jun 15, 2021 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Jun 16, 2021, 04:33 PM |
Machiels Alec | Director | Jun 15, 2021 | Sale | $64.83 | 2,500 | 162,075 | 669,544 | Jun 16, 2021, 04:33 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jun 14, 2021 | Sale | $61.84 | 500 | 30,920 | 54,930 | Jun 15, 2021, 04:03 PM |
Machiels Alec | Director | May 14, 2021 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | May 18, 2021, 04:05 PM |
Machiels Alec | Director | May 14, 2021 | Sale | $45.39 | 2,500 | 113,475 | 669,544 | May 18, 2021, 04:05 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | May 03, 2021 | Sale | $50.73 | 600 | 30,438 | 55,614 | May 04, 2021, 04:11 PM |
Deschatelets Pascal | Chief Scientific Officer | Apr 28, 2021 | Option Exercise | $2.67 | 4,500 | 12,015 | 869,587 | Apr 29, 2021, 05:11 PM |
Deschatelets Pascal | Chief Scientific Officer | Apr 23, 2021 | Option Exercise | $2.67 | 6,250 | 16,688 | 871,337 | Apr 26, 2021, 06:02 PM |
Deschatelets Pascal | Chief Scientific Officer | Apr 23, 2021 | Sale | $46.13 | 6,250 | 288,313 | 865,087 | Apr 26, 2021, 06:02 PM |
Watson David O. | General Counsel | Apr 22, 2021 | Option Exercise | $4.31 | 489 | 2,108 | 97,261 | Apr 23, 2021, 04:02 PM |
Machiels Alec | Director | Apr 21, 2021 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Apr 22, 2021, 06:17 PM |
Machiels Alec | Director | Apr 21, 2021 | Sale | $45.76 | 2,500 | 114,400 | 669,544 | Apr 22, 2021, 06:17 PM |
Dunlop A. Sinclair | Director | Apr 16, 2021 | Option Exercise | $14.00 | 50,000 | 700,000 | 50,000 | Apr 19, 2021, 07:29 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Apr 14, 2021 | Sale | $42.82 | 500 | 21,410 | 56,214 | Apr 15, 2021, 05:55 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Apr 01, 2021 | Sale | $43.41 | 600 | 26,046 | 56,714 | Apr 05, 2021, 05:11 PM |
Brown Victoria L. | Program Team Lead | Mar 25, 2021 | Option Exercise | $41.16 | 82 | 3,375 | 9,952 | Mar 29, 2021, 04:58 PM |
Watson David O. | General Counsel | Mar 22, 2021 | Option Exercise | $4.31 | 978 | 4,215 | 96,772 | Mar 23, 2021, 04:14 PM |
Machiels Alec | Director | Mar 15, 2021 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Mar 17, 2021, 04:16 PM |
Machiels Alec | Director | Mar 15, 2021 | Sale | $46.77 | 2,500 | 116,925 | 669,544 | Mar 17, 2021, 04:16 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Mar 15, 2021 | Sale | $46.77 | 500 | 23,385 | 57,314 | Mar 17, 2021, 04:14 PM |
Deschatelets Pascal | Chief Scientific Officer | Mar 10, 2021 | Option Exercise | $2.67 | 6,250 | 16,688 | 871,337 | Mar 11, 2021, 04:08 PM |
Deschatelets Pascal | Chief Scientific Officer | Mar 10, 2021 | Sale | $50.74 | 6,250 | 317,125 | 865,087 | Mar 11, 2021, 04:08 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Mar 05, 2021 | Option Exercise | $3.20 | 5,000 | 16,000 | 62,814 | Mar 08, 2021, 04:32 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Mar 05, 2021 | Sale | $48.62 | 5,000 | 243,075 | 57,814 | Mar 08, 2021, 04:32 PM |
Perry Nicole D | Vice President - Accounting | Mar 01, 2021 | Option Exercise | $3.76 | 2,000 | 7,520 | 4,347 | Mar 03, 2021, 04:05 PM |
Perry Nicole D | Vice President - Accounting | Mar 01, 2021 | Sale | $50.00 | 2,000 | 100,000 | 2,347 | Mar 03, 2021, 04:05 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Mar 01, 2021 | Sale | $48.58 | 600 | 29,148 | 57,814 | Mar 03, 2021, 04:03 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Feb 16, 2021 | Sale | $46.00 | 500 | 23,000 | 58,414 | Feb 17, 2021, 04:12 PM |
Machiels Alec | Director | Feb 16, 2021 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Feb 17, 2021, 04:11 PM |
Machiels Alec | Director | Feb 16, 2021 | Sale | $46.00 | 2,500 | 115,000 | 669,544 | Feb 17, 2021, 04:11 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Feb 10, 2021 | Option Exercise | $47.72 | 680 | 32,450 | 29,290 | Feb 11, 2021, 04:18 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Feb 10, 2021 | Option Exercise | $47.72 | 858 | 40,944 | 34,261 | Feb 11, 2021, 04:16 PM |
Perry Nicole D | Vice President - Accounting | Feb 10, 2021 | Option Exercise | $47.72 | 153 | 7,301 | 2,347 | Feb 11, 2021, 04:14 PM |
Deschatelets Pascal | Chief Scientific Officer | Feb 10, 2021 | Option Exercise | $47.72 | 688 | 32,831 | 865,087 | Feb 11, 2021, 04:12 PM |
Townsend Adam J. | Chief Commercial Officer | Feb 10, 2021 | Option Exercise | $47.72 | 688 | 32,831 | 18,865 | Feb 11, 2021, 04:10 PM |
Brown Victoria L. | Program Team Lead | Feb 10, 2021 | Option Exercise | $47.72 | 144 | 6,872 | 8,784 | Feb 11, 2021, 04:07 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Feb 10, 2021 | Option Exercise | $47.72 | 688 | 32,831 | 58,914 | Feb 11, 2021, 04:06 PM |
Francois Cedric | Chief Executive Officer | Feb 10, 2021 | Option Exercise | $47.72 | 2,523 | 120,398 | 1,219,833 | Feb 11, 2021, 04:05 PM |
Francois Cedric | Chief Executive Officer | Feb 10, 2021 | Option Exercise | $47.72 | 2,523 | 120,398 | 1,219,833 | Feb 11, 2021, 04:05 PM |
Watson David O. | General Counsel | Feb 10, 2021 | Option Exercise | $47.72 | 468 | 22,333 | 95,794 | Feb 11, 2021, 04:02 PM |
Perry Nicole D | Vice President - Accounting | Feb 09, 2021 | Option Exercise | $3.76 | 2,000 | 7,520 | 4,500 | Feb 10, 2021, 04:37 PM |
Perry Nicole D | Vice President - Accounting | Feb 09, 2021 | Sale | $50.00 | 2,000 | 100,000 | 2,500 | Feb 10, 2021, 04:37 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Feb 01, 2021 | Sale | $44.00 | 600 | 26,400 | 59,602 | Feb 02, 2021, 04:08 PM |
Francois Cedric | Chief Executive Officer | Jan 27, 2021 | Option Exercise | $4.01 | 71,777 | 287,477 | 1,184,856 | Jan 29, 2021, 04:19 PM |
Watson David O. | General Counsel | Jan 27, 2021 | Option Exercise | $4.01 | 43,483 | 174,519 | 86,887 | Jan 29, 2021, 04:18 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jan 25, 2021 | Option Exercise | $3.63 | 15,000 | 54,440 | 50,827 | Jan 26, 2021, 04:25 PM |
Machiels Alec | Director | Jan 15, 2021 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Jan 19, 2021, 04:05 PM |
Machiels Alec | Director | Jan 15, 2021 | Sale | $53.15 | 2,500 | 132,875 | 669,544 | Jan 19, 2021, 04:05 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jan 14, 2021 | Sale | $51.99 | 4,000 | 207,960 | 35,827 | Jan 15, 2021, 04:10 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Jan 04, 2021 | Sale | $57.24 | 600 | 34,344 | 39,827 | Jan 05, 2021, 04:21 PM |
Perry Nicole D | Vice President - Accounting | Jan 04, 2021 | Option Exercise | $3.76 | 2,000 | 7,520 | 2,000 | Jan 05, 2021, 12:00 AM |
Perry Nicole D | Vice President - Accounting | Jan 04, 2021 | Sale | $57.24 | 2,000 | 114,480 | 0 | Jan 05, 2021, 12:00 AM |
Machiels Alec | Director | Dec 15, 2020 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Dec 16, 2020, 04:36 PM |
Machiels Alec | Director | Dec 15, 2020 | Sale | $52.16 | 2,500 | 130,400 | 669,544 | Dec 16, 2020, 04:36 PM |
Francois Cedric | Chief Executive Officer | Dec 15, 2020 | Sale | $52.16 | 5,000 | 260,800 | 1,113,079 | Dec 16, 2020, 04:35 PM |
Dunlop A. Sinclair | Director | Dec 14, 2020 | Sale | $54.67 | 25,000 | 1,366,713 | 192,074 | Dec 15, 2020, 05:05 PM |
Watson David O. | General Counsel | Dec 11, 2020 | Option Exercise | $13.85 | 9,935 | 137,600 | 53,339 | Dec 15, 2020, 04:03 PM |
Watson David O. | General Counsel | Dec 14, 2020 | Option Exercise | $13.85 | 8,398 | 116,312 | 51,802 | Dec 15, 2020, 04:03 PM |
Watson David O. | General Counsel | Dec 14, 2020 | Sale | $52.06 | 8,398 | 437,197 | 49,093 | Dec 15, 2020, 04:03 PM |
Watson David O. | General Counsel | Dec 11, 2020 | Sale | $50.00 | 9,935 | 496,750 | 43,404 | Dec 15, 2020, 04:03 PM |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | Dec 08, 2020 | Option Exercise | $26.73 | 7,482 | 199,994 | 20,595 | Dec 09, 2020, 05:34 PM |
Perry Nicole D | Vice President - Accounting | Dec 04, 2020 | Option Exercise | $3.76 | 18,000 | 67,680 | 18,000 | Dec 08, 2020, 07:32 PM |
Perry Nicole D | Vice President - Accounting | Dec 04, 2020 | Sale | $50.00 | 18,000 | 900,000 | 0 | Dec 08, 2020, 07:32 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Dec 04, 2020 | Option Exercise | $3.20 | 7,250 | 23,200 | 40,427 | Dec 08, 2020, 07:21 PM |
Dunlop A. Sinclair | Director | Dec 07, 2020 | Sale | $50.71 | 18,564 | 941,399 | 209,198 | Dec 07, 2020, 06:58 PM |
Dunlop A. Sinclair | Director | Dec 04, 2020 | Sale | $50.26 | 6,436 | 323,455 | 219,676 | Dec 07, 2020, 06:58 PM |
Francois Cedric | Chief Executive Officer | Dec 01, 2020 | Option Exercise | $3.76 | 40,000 | 150,400 | 1,118,079 | Dec 02, 2020, 04:31 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Dec 01, 2020 | Sale | $48.25 | 600 | 28,950 | 33,177 | Dec 02, 2020, 04:30 PM |
Francois Cedric | Chief Executive Officer | Nov 16, 2020 | Sale | $39.38 | 5,000 | 196,900 | 1,078,079 | Nov 17, 2020, 07:13 PM |
Machiels Alec | Director | Nov 16, 2020 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Nov 17, 2020, 07:12 PM |
Machiels Alec | Director | Nov 16, 2020 | Sale | $39.38 | 2,500 | 98,450 | 669,544 | Nov 17, 2020, 07:12 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Nov 16, 2020 | Option Exercise | $3.20 | 5,750 | 18,400 | 33,777 | Nov 17, 2020, 07:11 PM |
Grossi Federico | CHIEF MEDICAL OFFICER | Nov 02, 2020 | Sale | $31.09 | 600 | 18,654 | 27,725 | Nov 03, 2020, 04:01 PM |
Machiels Alec | Director | Oct 15, 2020 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Oct 16, 2020, 05:56 PM |
Machiels Alec | Director | Oct 15, 2020 | Sale | $35.00 | 2,500 | 87,500 | 669,544 | Oct 16, 2020, 05:56 PM |
Francois Cedric | Chief Executive Officer | Oct 15, 2020 | Sale | $34.46 | 5,000 | 172,300 | 1,083,079 | Oct 16, 2020, 05:31 PM |
Machiels Alec | Director | Oct 07, 2020 | Option Exercise | $2.67 | 7,500 | 20,025 | 677,044 | Oct 09, 2020, 04:48 PM |
Machiels Alec | Director | Oct 07, 2020 | Sale | $35.00 | 7,500 | 262,500 | 669,544 | Oct 09, 2020, 04:48 PM |
Brown Victoria L. | Program Team Lead | Oct 07, 2020 | Option Exercise | $18.98 | 12,000 | 227,760 | 15,607 | Oct 09, 2020, 04:45 PM |
Brown Victoria L. | Program Team Lead | Oct 07, 2020 | Sale | $35.00 | 12,000 | 420,000 | 3,607 | Oct 09, 2020, 04:45 PM |
Grossi Federico | See Remarks | Oct 01, 2020 | Sale | $30.22 | 600 | 18,132 | 28,325 | Oct 02, 2020, 04:14 PM |
Francois Cedric | Chief Executive Officer | Sep 15, 2020 | Sale | $30.96 | 5,000 | 154,800 | 1,088,079 | Sep 16, 2020, 04:03 PM |
Grossi Federico | See Remarks | Sep 01, 2020 | Sale | $31.58 | 600 | 18,948 | 28,925 | Sep 02, 2020, 04:36 PM |
Francois Cedric | Chief Executive Officer | Aug 20, 2020 | Sale | $30.00 | 3,457 | 103,710 | 1,093,079 | Aug 21, 2020, 04:36 PM |
Francois Cedric | Chief Executive Officer | Aug 18, 2020 | Sale | $30.00 | 1,543 | 46,290 | 1,096,536 | Aug 20, 2020, 04:45 PM |
Grossi Federico | See Remarks | Aug 03, 2020 | Sale | $26.28 | 600 | 15,768 | 29,525 | Aug 05, 2020, 04:37 PM |
Francois Cedric | Chief Executive Officer | Jul 15, 2020 | Sale | $32.12 | 5,000 | 160,600 | 1,098,079 | Jul 16, 2020, 04:07 PM |
Grossi Federico | See Remarks | Jul 01, 2020 | Sale | $32.43 | 850 | 27,566 | 30,125 | Jul 02, 2020, 05:48 PM |
Grossi Federico | See Remarks | Jun 15, 2020 | Sale | $30.21 | 856 | 25,860 | 30,975 | Jun 16, 2020, 04:41 PM |
Machiels Alec | Director | Jun 15, 2020 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Jun 16, 2020, 04:40 PM |
Machiels Alec | Director | Jun 15, 2020 | Sale | $30.21 | 2,500 | 75,525 | 669,544 | Jun 16, 2020, 04:40 PM |
Francois Cedric | Chief Executive Officer | Jun 15, 2020 | Sale | $30.21 | 5,000 | 151,050 | 1,103,079 | Jun 16, 2020, 04:39 PM |
Francois Cedric | Chief Executive Officer | May 15, 2020 | Sale | $29.92 | 5,000 | 149,600 | 1,108,079 | May 19, 2020, 04:27 PM |
Machiels Alec | Director | May 15, 2020 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | May 19, 2020, 04:27 PM |
Machiels Alec | Director | May 15, 2020 | Sale | $30.00 | 2,500 | 75,000 | 669,544 | May 19, 2020, 04:27 PM |
FONTEYNE PAUL R. | Director | May 08, 2020 | Buy | $31.81 | 5,000 | 159,034 | 5,000 | May 12, 2020, 05:53 PM |
Francois Cedric | Chief Executive Officer | Apr 15, 2020 | Sale | $29.77 | 5,000 | 148,850 | 1,113,079 | Apr 17, 2020, 07:32 PM |
Machiels Alec | Director | Apr 15, 2020 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Apr 17, 2020, 07:28 PM |
Machiels Alec | Director | Apr 15, 2020 | Sale | $30.00 | 2,500 | 75,000 | 669,544 | Apr 17, 2020, 07:28 PM |
Machiels Alec | Director | Mar 25, 2020 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Mar 26, 2020, 04:01 PM |
Machiels Alec | Director | Mar 25, 2020 | Sale | $30.00 | 2,500 | 75,000 | 669,544 | Mar 26, 2020, 04:01 PM |
Francois Cedric | Chief Executive Officer | Mar 17, 2020 | Option Exercise | $2.14 | 30,637 | 65,563 | 1,083,704 | Mar 18, 2020, 04:51 PM |
Francois Cedric | Chief Executive Officer | Mar 16, 2020 | Option Exercise | $2.14 | 30,637 | 65,563 | 1,088,704 | Mar 18, 2020, 04:51 PM |
Francois Cedric | Chief Executive Officer | Mar 16, 2020 | Sale | $21.32 | 35,637 | 759,934 | 1,086,596 | Mar 18, 2020, 04:51 PM |
Francois Cedric | Chief Executive Officer | Feb 18, 2020 | Option Exercise | $2.14 | 30,637 | 65,563 | 1,063,067 | Feb 20, 2020, 04:07 PM |
Francois Cedric | Chief Executive Officer | Feb 19, 2020 | Option Exercise | $2.14 | 30,637 | 65,563 | 1,058,067 | Feb 20, 2020, 04:07 PM |
Francois Cedric | Chief Executive Officer | Feb 18, 2020 | Sale | $40.66 | 35,637 | 1,449,122 | 1,032,430 | Feb 20, 2020, 04:07 PM |
Machiels Alec | Director | Feb 14, 2020 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Feb 19, 2020, 12:00 AM |
Machiels Alec | Director | Feb 14, 2020 | Sale | $42.35 | 2,500 | 105,875 | 669,544 | Feb 19, 2020, 12:00 AM |
Deschatelets Pascal | Chief Operating Officer | Feb 12, 2020 | Option Exercise | $2.14 | 117,206 | 250,821 | 998,949 | Feb 14, 2020, 04:49 PM |
Deschatelets Pascal | Chief Operating Officer | Feb 13, 2020 | Option Exercise | $2.14 | 117,205 | 250,819 | 1,064,079 | Feb 14, 2020, 04:49 PM |
Deschatelets Pascal | Chief Operating Officer | Feb 12, 2020 | Sale | $42.80 | 52,075 | 2,228,966 | 946,874 | Feb 14, 2020, 04:49 PM |
Deschatelets Pascal | Chief Operating Officer | Feb 13, 2020 | Sale | $40.98 | 55,398 | 2,270,155 | 1,008,681 | Feb 14, 2020, 04:49 PM |
Watson David O. | General Counsel | Feb 10, 2020 | Option Exercise | $2.67 | 7,505 | 20,038 | 42,922 | Feb 12, 2020, 04:38 PM |
Watson David O. | General Counsel | Feb 10, 2020 | Sale | $44.50 | 5,000 | 222,500 | 35,417 | Feb 12, 2020, 04:38 PM |
Watson David O. | General Counsel | Jan 27, 2020 | Option Exercise | $2.67 | 15,000 | 40,050 | 34,042 | Jan 28, 2020, 05:08 PM |
Watson David O. | General Counsel | Jan 27, 2020 | Sale | $40.47 | 3,000 | 121,401 | 19,042 | Jan 28, 2020, 05:08 PM |
Morningside Venture Investments Ltd | 10% Owner | Jan 13, 2020 | Buy | $37.00 | 540,540 | 19,999,980 | 12,556,342 | Jan 21, 2020, 05:47 PM |
Francois Cedric | Chief Executive Officer | Jan 16, 2020 | Option Exercise | $2.14 | 30,637 | 65,563 | 1,032,430 | Jan 21, 2020, 09:22 AM |
Francois Cedric | Chief Executive Officer | Jan 15, 2020 | Option Exercise | $2.14 | 30,638 | 65,565 | 1,001,793 | Jan 17, 2020, 04:11 PM |
Francois Cedric | Chief Executive Officer | Jan 15, 2020 | Sale | $42.11 | 35,638 | 1,500,788 | 1,011,355 | Jan 17, 2020, 04:11 PM |
Machiels Alec | Director | Jan 15, 2020 | Option Exercise | $2.67 | 2,500 | 6,675 | 672,044 | Jan 17, 2020, 04:08 PM |
Machiels Alec | Director | Jan 15, 2020 | Sale | $41.47 | 2,500 | 103,675 | 669,544 | Jan 17, 2020, 04:08 PM |
Dunlop A. Sinclair | Director | Dec 19, 2019 | Sale | $29.18 | 85,110 | 2,483,459 | 320,681 | Dec 20, 2019, 05:11 PM |
Dunlop A. Sinclair | Director | Dec 18, 2019 | Sale | $28.55 | 25,890 | 739,159 | 374,791 | Dec 20, 2019, 05:11 PM |
Dunlop A. Sinclair | Director | Dec 20, 2019 | Sale | $29.53 | 25,000 | 738,250 | 224,728 | Dec 20, 2019, 05:11 PM |
Francois Cedric | Chief Executive Officer | Dec 16, 2019 | Sale | $27.95 | 5,000 | 139,750 | 1,006,793 | Dec 17, 2019, 04:47 PM |
Francois Cedric | Chief Executive Officer | Nov 15, 2019 | Sale | $27.28 | 5,000 | 136,405 | 1,011,793 | Nov 18, 2019, 04:21 PM |
Francois Cedric | Chief Executive Officer | Oct 15, 2019 | Sale | $26.31 | 5,000 | 131,551 | 1,020,317 | Oct 16, 2019, 04:02 PM |
Deschatelets Pascal | Chief Operating Officer | Sep 25, 2019 | Sale | $25.26 | 21,541 | 544,059 | 882,753 | Sep 26, 2019, 04:06 PM |
Deschatelets Pascal | Chief Operating Officer | Sep 23, 2019 | Sale | $25.07 | 20,858 | 522,915 | 924,986 | Sep 25, 2019, 04:26 PM |
Deschatelets Pascal | Chief Operating Officer | Sep 24, 2019 | Sale | $24.58 | 21,602 | 531,081 | 904,579 | Sep 25, 2019, 04:26 PM |
Francois Cedric | Chief Executive Officer | Sep 16, 2019 | Sale | $26.59 | 5,000 | 132,949 | 1,022,053 | Sep 17, 2019, 07:29 PM |
Sullivan Timothy Eugene | Chief Financial Officer | Aug 29, 2019 | Buy | $29.71 | 11,699 | 347,630 | 11,699 | Sep 03, 2019, 04:13 PM |
Francois Cedric | Chief Executive Officer | Aug 23, 2019 | Option Exercise | $2.67 | 37,505 | 100,138 | 1,026,793 | Aug 26, 2019, 04:10 PM |
Francois Cedric | Chief Executive Officer | Aug 15, 2019 | Option Exercise | $2.14 | 10,000 | 21,400 | 999,288 | Aug 16, 2019, 04:08 PM |
Francois Cedric | Chief Executive Officer | Aug 15, 2019 | Sale | $26.80 | 10,000 | 268,007 | 991,534 | Aug 16, 2019, 04:08 PM |
Watson David O. | General Counsel | Aug 07, 2019 | Option Exercise | $2.67 | 5,000 | 13,350 | 22,042 | Aug 09, 2019, 08:48 AM |
Francois Cedric | Chief Executive Officer | Jun 27, 2019 | Option Exercise | $2.14 | 275,000 | 588,500 | 989,288 | Jul 01, 2019, 04:09 PM |
Morningside Venture Investments Ltd | 10% Owner | Mar 11, 2019 | Buy | $17.00 | 441,176 | 7,499,992 | 12,015,802 | Mar 13, 2019, 03:32 PM |
Grossi Federico | See Remarks | Nov 14, 2018 | Option Exercise | $3.20 | 6,250 | 20,000 | 22,456 | Nov 15, 2018, 08:45 PM |
Axon Steven | Chief Business Officer | Nov 14, 2018 | Option Exercise | $2.59 | 11,500 | 29,785 | 50,110 | Nov 15, 2018, 08:40 PM |
Morningside Venture Investments Ltd | 10% Owner | Sep 20, 2018 | Buy | $19.13 | 41,323 | 790,363 | 11,534,626 | Sep 24, 2018, 06:05 PM |
Morningside Venture Investments Ltd | 10% Owner | Sep 21, 2018 | Buy | $19.84 | 40,000 | 793,600 | 11,574,626 | Sep 24, 2018, 06:05 PM |
Morningside Venture Investments Ltd | 10% Owner | Sep 19, 2018 | Buy | $18.09 | 60,000 | 1,085,400 | 11,493,303 | Sep 19, 2018, 07:42 PM |
Morningside Venture Investments Ltd | 10% Owner | Sep 18, 2018 | Buy | $18.47 | 40,000 | 738,800 | 11,433,303 | Sep 19, 2018, 07:42 PM |
Morningside Venture Investments Ltd | 10% Owner | Sep 17, 2018 | Buy | $18.57 | 40,000 | 742,924 | 11,393,303 | Sep 19, 2018, 07:42 PM |
Watson David O. | General Counsel | Sep 14, 2018 | Option Exercise | $2.67 | 32,818 | 87,624 | 32,818 | Sep 17, 2018, 05:40 PM |
Watson David O. | General Counsel | Sep 14, 2018 | Sale | $18.78 | 15,776 | 296,336 | 17,042 | Sep 17, 2018, 05:40 PM |
Watson David O. | General Counsel | May 29, 2018 | Option Exercise | $2.67 | 624 | 1,666 | 624 | May 30, 2018, 08:31 PM |
SCHEIBLER LUKAS | See Remarks | May 24, 2018 | Buy | $20.37 | 2,935 | 59,786 | 2,935 | May 29, 2018, 04:17 PM |
Grossi Federico | See Remarks | Apr 11, 2018 | Option Exercise | $3.20 | 8,500 | 27,200 | 8,500 | Apr 12, 2018, 04:08 PM |
Axon Steven | Chief Business Officer | Feb 20, 2018 | Option Exercise | $2.59 | 38,610 | 100,000 | 38,610 | Feb 21, 2018, 05:13 PM |
Hillhouse Capital Management, Ltd. | 10% Owner | Nov 13, 2017 | Buy | $14.00 | 1,428,571 | 19,999,994 | 3,527,152 | Nov 15, 2017, 04:32 PM |
Cormorant Asset Management, LLC | 10% Owner | Nov 13, 2017 | Buy | $14.00 | 1,071,428 | 14,999,992 | 3,473,925 | Nov 14, 2017, 04:31 PM |
venBio Global Strategic Fund II L.P. | 10% Owner | Nov 13, 2017 | Buy | $14.00 | 127,515 | 1,785,210 | 3,579,305 | Nov 13, 2017, 04:27 PM |
Morningside Venture Investments Ltd | 10% Owner | Nov 13, 2017 | Buy | $14.00 | 575,000 | 8,050,000 | 11,353,303 | Nov 13, 2017, 04:26 PM |
Owner | Relationship | Date | Value($) |
Dunlop A. Sinclair | Director | 04/12/2024 | 19,785 |
Deschatelets Pascal | Chief Scientific Officer | 04/08/2024 | 259,842 |
Deschatelets Pascal | Chief Scientific Officer | 04/08/2024 | 3,743,605 |
Sullivan Timothy Eugene | Chief Financial Officer | 04/01/2024 | 40,120 |
Sullivan Timothy Eugene | Chief Financial Officer | 04/01/2024 | 234,640 |
Dunlop A. Sinclair | Director | 03/19/2024 | 1,068,161 |
DeLong Mark Jeffrey | Chief Business & Strat Officer | 03/18/2024 | 564,050 |
Chopas James George | VP/Chief Accounting Officer | 03/15/2024 | 10,389 |
Nicholson Nur | Chief Technical Officer | 03/13/2024 | 645,838 |
Deschatelets Pascal | Chief Scientific Officer | 03/08/2024 | 253,623 |
Deschatelets Pascal | Chief Scientific Officer | 03/08/2024 | 4,297,549 |
Watson David O. | General Counsel | 03/06/2024 | 52,104 |
Francois Cedric | Chief Executive Officer | 03/01/2024 | 1,050,000 |
Francois Cedric | Chief Executive Officer | 03/01/2024 | 16,028,706 |
Sullivan Timothy Eugene | Chief Financial Officer | 03/01/2024 | 60,180 |
Sullivan Timothy Eugene | Chief Financial Officer | 03/01/2024 | 379,340 |
Watson David O. | General Counsel | 02/12/2024 | 52,926 |
Townsend Adam J. | Chief Commercial Officer | 02/12/2024 | 77,796 |
Sullivan Timothy Eugene | Chief Financial Officer | 02/12/2024 | 96,974 |
Francois Cedric | Chief Executive Officer | 02/12/2024 | 268,492 |
Deschatelets Pascal | Chief Scientific Officer | 02/12/2024 | 77,796 |
DeLong Mark Jeffrey | Chief Business & Strat Officer | 02/12/2024 | 40,457 |
Watson David O. | General Counsel | 01/29/2024 | 58,109 |
Townsend Adam J. | Chief Commercial Officer | 01/29/2024 | 58,109 |
Sullivan Timothy Eugene | Chief Financial Officer | 01/29/2024 | 58,109 |
Nicholson Nur | Chief Technical Officer | 01/29/2024 | 53,555 |
Lewis Karen | Chief People Officer | 01/30/2024 | 57,863 |
Lewis Karen | Chief People Officer | 01/29/2024 | 23,539 |
Francois Cedric | Chief Executive Officer | 01/29/2024 | 182,345 |
Eisele Jeffrey | Chief Development Officer | 01/29/2024 | 17,895 |
Eisele Jeffrey | Chief Development Officer | 01/30/2024 | 63,630 |
Deschatelets Pascal | Chief Scientific Officer | 01/29/2024 | 56,057 |
DeLong Mark Jeffrey | Chief Business & Strat Officer | 01/29/2024 | 23,539 |
Lewis Karen | Chief People Officer | 01/23/2024 | 272,975 |
Eisele Jeffrey | Chief Development Officer | 01/23/2024 | 469,905 |
Francois Cedric | Chief Executive Officer | 01/22/2024 | 872,961 |
Watson David O. | General Counsel | 01/22/2024 | 271,943 |
Townsend Adam J. | Chief Commercial Officer | 01/22/2024 | 221,831 |
Sullivan Timothy Eugene | Chief Financial Officer | 01/22/2024 | 230,801 |
Nicholson Nur | Chief Technical Officer | 01/22/2024 | 168,535 |
Lewis Karen | Chief People Officer | 01/22/2024 | 112,963 |
Eisele Jeffrey | Chief Development Officer | 01/22/2024 | 104,449 |
Deschatelets Pascal | Chief Scientific Officer | 01/22/2024 | 254,329 |
DeLong Mark Jeffrey | Chief Business & Strat Officer | 01/22/2024 | 89,954 |
Chopas James George | VP/Chief Accounting Officer | 01/22/2024 | 68,961 |
Eisele Jeffrey | Chief Development Officer | 01/17/2024 | 341,475 |
Lewis Karen | Chief People Officer | 01/17/2024 | 214,840 |
Deschatelets Pascal | Chief Scientific Officer | 01/16/2024 | 109,032 |
Chopas James George | VP/Chief Accounting Officer | 01/16/2024 | 57,723 |
Lewis Karen | Chief People Officer | 01/16/2024 | 109,032 |
DeLong Mark Jeffrey | Chief Business & Strat Officer | 01/16/2024 | 108,965 |
Nicholson Nur | Chief Technical Officer | 01/16/2024 | 124,064 |
Watson David O. | General Counsel | 01/16/2024 | 283,268 |
Townsend Adam J. | Chief Commercial Officer | 01/16/2024 | 149,317 |
Sullivan Timothy Eugene | Chief Financial Officer | 01/16/2024 | 149,317 |
Francois Cedric | Chief Executive Officer | 01/16/2024 | 524,514 |
Eisele Jeffrey | Chief Development Officer | 01/16/2024 | 29,262 |
Baumal Caroline | Chief Medical Officer | 01/04/2024 | 165,207 |
Eisele Jeffrey | Chief Development Officer | 12/27/2023 | 14,154 |
Eisele Jeffrey | Chief Development Officer | 12/26/2023 | 3,935 |
Watson David O. | General Counsel | 12/19/2023 | 109,484 |
Watson David O. | General Counsel | 12/19/2023 | 223,472 |
Dunlop A. Sinclair | Director | 12/14/2023 | 82,754 |
SCHEIBLER LUKAS | Chief Research Officer | 12/01/2023 | 138,500 |
SCHEIBLER LUKAS | Chief Research Officer | 12/01/2023 | 600,000 |
Townsend Adam J. | Chief Commercial Officer | 12/01/2023 | 1,659,900 |
Townsend Adam J. | Chief Commercial Officer | 12/01/2023 | 6,689,303 |
Dunlop A. Sinclair | Director | 12/01/2023 | 1,467,240 |
Sullivan Timothy Eugene | Chief Financial Officer | 11/30/2023 | 142,005 |
Sullivan Timothy Eugene | Chief Financial Officer | 11/30/2023 | 774,884 |
Francois Cedric | Chief Executive Officer | 11/21/2023 | 244,000 |
Dunlop A. Sinclair | Director | 11/17/2023 | 444,620 |
Dunlop A. Sinclair | Director | 10/17/2023 | 1,176,000 |
Machiels Alec | Director | 11/17/2023 | 3,338 |
Machiels Alec | Director | 11/17/2023 | 59,675 |
Deschatelets Pascal | Chief Scientific Officer | 11/14/2023 | 169,200 |
Deschatelets Pascal | Chief Scientific Officer | 11/08/2023 | 46,709 |
Deschatelets Pascal | Chief Scientific Officer | 11/08/2023 | 567,240 |
Chopas James George | VP/Chief Accounting Officer | 10/23/2023 | 6,077 |
DeLong Mark Jeffrey | Chief Business & Strat Officer | 10/23/2023 | 6,031 |
Machiels Alec | Director | 10/17/2023 | 3,338 |
Machiels Alec | Director | 10/17/2023 | 60,625 |
Deschatelets Pascal | Chief Scientific Officer | 10/09/2023 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 10/09/2023 | 484,560 |
Machiels Alec | Director | 09/18/2023 | 3,338 |
Machiels Alec | Director | 09/18/2023 | 56,250 |
Nicholson Nur | Chief Technical Officer | 09/18/2023 | 289,237 |
Nicholson Nur | Chief Technical Officer | 09/18/2023 | 900,813 |
Machiels Alec | Director | 09/15/2023 | 3,338 |
Machiels Alec | Director | 09/15/2023 | 56,675 |
Deschatelets Pascal | Chief Scientific Officer | 09/08/2023 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 09/08/2023 | 514,440 |
SCHEIBLER LUKAS | Chief Research Officer | 09/06/2023 | 75,526 |
Chopas James George | VP/Chief Accounting Officer | 08/31/2023 | 22,716 |
Francois Cedric | Chief Executive Officer | 09/01/2023 | 801,000 |
Francois Cedric | Chief Executive Officer | 09/01/2023 | 6,262,959 |
Deschatelets Pascal | Chief Scientific Officer | 08/08/2023 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 08/08/2023 | 283,920 |
Machiels Alec | Director | 07/21/2023 | 132,910 |
Machiels Alec | Director | 07/20/2023 | 133,500 |
Machiels Alec | Director | 07/17/2023 | 3,338 |
Machiels Alec | Director | 07/17/2023 | 80,988 |
Deschatelets Pascal | Chief Scientific Officer | 07/10/2023 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 07/10/2023 | 1,014,600 |
Watson David O. | General Counsel | 07/03/2023 | 765,730 |
Sullivan Timothy Eugene | Chief Financial Officer | 07/03/2023 | 67,993 |
Sullivan Timothy Eugene | Chief Financial Officer | 07/03/2023 | 609,928 |
Machiels Alec | Director | 06/20/2023 | 3,338 |
Machiels Alec | Director | 06/20/2023 | 110,513 |
Deschatelets Pascal | Chief Scientific Officer | 06/08/2023 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 06/08/2023 | 1,096,200 |
Sullivan Timothy Eugene | Chief Financial Officer | 06/05/2023 | 699,883 |
Sullivan Timothy Eugene | Chief Financial Officer | 06/05/2023 | 6,196,527 |
Lewis Karen | Chief People Officer | 06/01/2023 | 170,550 |
Lewis Karen | Chief People Officer | 06/01/2023 | 430,000 |
Machiels Alec | Director | 05/17/2023 | 3,338 |
Machiels Alec | Director | 05/17/2023 | 110,825 |
Francois Cedric | Chief Executive Officer | 05/17/2023 | 53,400 |
Francois Cedric | Chief Executive Officer | 05/16/2023 | 80,100 |
Francois Cedric | Chief Executive Officer | 05/16/2023 | 2,569,900 |
Deschatelets Pascal | Chief Scientific Officer | 05/08/2023 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 05/08/2023 | 1,108,680 |
Townsend Adam J. | Chief Commercial Officer | 05/03/2023 | 75,450 |
Townsend Adam J. | Chief Commercial Officer | 05/03/2023 | 413,550 |
Francois Cedric | Chief Executive Officer | 04/19/2023 | 53,400 |
Francois Cedric | Chief Executive Officer | 04/18/2023 | 80,100 |
Francois Cedric | Chief Executive Officer | 04/18/2023 | 2,460,720 |
Machiels Alec | Director | 04/17/2023 | 3,338 |
Machiels Alec | Director | 04/17/2023 | 101,313 |
Deschatelets Pascal | Chief Scientific Officer | 04/10/2023 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 04/10/2023 | 938,520 |
Dunlop A. Sinclair | Director | 04/03/2023 | 37,025 |
Lewis Karen | Chief People Officer | 04/03/2023 | 170,550 |
Lewis Karen | Chief People Officer | 04/03/2023 | 375,000 |
Townsend Adam J. | Chief Commercial Officer | 04/03/2023 | 75,450 |
Townsend Adam J. | Chief Commercial Officer | 04/03/2023 | 370,250 |
Francois Cedric | Chief Executive Officer | 03/22/2023 | 529,411 |
Francois Cedric | Chief Executive Officer | 03/21/2023 | 80,100 |
Francois Cedric | Chief Executive Officer | 03/21/2023 | 1,882,332 |
Machiels Alec | Director | 03/17/2023 | 3,338 |
Machiels Alec | Director | 03/17/2023 | 80,037 |
Deschatelets Pascal | Chief Scientific Officer | 03/08/2023 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 03/08/2023 | 765,480 |
Townsend Adam J. | Chief Commercial Officer | 03/03/2023 | 75,450 |
Townsend Adam J. | Chief Commercial Officer | 03/03/2023 | 319,200 |
Francois Cedric | Chief Executive Officer | 02/27/2023 | 376,000 |
Eisele Jeffrey | Chief Development Officer | 02/23/2023 | 113,179 |
Lewis Karen | Chief People Officer | 02/23/2023 | 75,911 |
Lewis Karen | Chief People Officer | 02/21/2023 | 32,351 |
SCHEIBLER LUKAS | Chief Research Officer | 02/21/2023 | 41,828 |
DeLong Mark Jeffrey | Chief Business & Strat Officer | 02/21/2023 | 25,799 |
Eisele Jeffrey | Chief Development Officer | 02/21/2023 | 48,263 |
Nicholson Nur | Chief Technical Officer | 02/21/2023 | 48,263 |
Chopas James George | VP/Chief Accounting Officer | 02/21/2023 | 19,539 |
Deschatelets Pascal | Chief Scientific Officer | 02/21/2023 | 69,908 |
Sullivan Timothy Eugene | Chief Financial Officer | 02/21/2023 | 56,979 |
Watson David O. | General Counsel | 02/21/2023 | 48,263 |
Francois Cedric | Chief Executive Officer | 02/21/2023 | 93,717 |
Townsend Adam J. | Chief Commercial Officer | 02/21/2023 | 60,899 |
Machiels Alec | Director | 02/17/2023 | 3,338 |
Machiels Alec | Director | 02/17/2023 | 65,475 |
Watson David O. | General Counsel | 02/10/2023 | 27,244 |
Townsend Adam J. | Chief Commercial Officer | 02/10/2023 | 40,046 |
Sullivan Timothy Eugene | Chief Financial Officer | 02/10/2023 | 49,930 |
SCHEIBLER LUKAS | Chief Research Officer | 02/10/2023 | 34,720 |
Francois Cedric | Chief Executive Officer | 02/10/2023 | 202,689 |
Deschatelets Pascal | Chief Scientific Officer | 02/10/2023 | 58,072 |
DeLong Mark Jeffrey | Chief Business & Strat Officer | 02/10/2023 | 34,311 |
Deschatelets Pascal | Chief Scientific Officer | 02/08/2023 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 02/08/2023 | 653,400 |
Townsend Adam J. | Chief Commercial Officer | 02/03/2023 | 75,450 |
Townsend Adam J. | Chief Commercial Officer | 02/03/2023 | 279,250 |
Dunlop A. Sinclair | Director | 02/01/2023 | 26,305 |
Eisele Jeffrey | Chief Development Officer | 01/30/2023 | 46,587 |
Lewis Karen | Chief People Officer | 01/30/2023 | 46,587 |
Watson David O. | General Counsel | 01/27/2023 | 29,076 |
Townsend Adam J. | Chief Commercial Officer | 01/27/2023 | 29,076 |
Sullivan Timothy Eugene | Chief Financial Officer | 01/27/2023 | 29,076 |
SCHEIBLER LUKAS | Chief Research Officer | 01/27/2023 | 28,601 |
Nicholson Nur | Chief Technical Officer | 01/27/2023 | 29,076 |
Lewis Karen | Chief People Officer | 01/27/2023 | 19,367 |
Francois Cedric | Chief Executive Officer | 01/27/2023 | 151,925 |
Eisele Jeffrey | Chief Development Officer | 01/27/2023 | 19,367 |
Deschatelets Pascal | Chief Scientific Officer | 01/27/2023 | 43,905 |
DeLong Mark Jeffrey | Chief Business & Strat Officer | 01/27/2023 | 19,367 |
Lewis Karen | Chief People Officer | 01/23/2023 | 152,419 |
Eisele Jeffrey | Chief Development Officer | 01/23/2023 | 231,027 |
Watson David O. | General Counsel | 01/20/2023 | 105,870 |
Townsend Adam J. | Chief Commercial Officer | 01/20/2023 | 99,520 |
Sullivan Timothy Eugene | Chief Financial Officer | 01/20/2023 | 123,827 |
SCHEIBLER LUKAS | Chief Research Officer | 01/20/2023 | 104,881 |
Nicholson Nur | Chief Technical Officer | 01/20/2023 | 105,870 |
Lewis Karen | Chief People Officer | 01/20/2023 | 73,443 |
Francois Cedric | Chief Executive Officer | 01/20/2023 | 492,029 |
Eisele Jeffrey | Chief Development Officer | 01/20/2023 | 105,818 |
Deschatelets Pascal | Chief Scientific Officer | 01/20/2023 | 121,068 |
DeLong Mark Jeffrey | Chief Business & Strat Officer | 01/20/2023 | 59,805 |
Chopas James George | VP/Chief Accounting Officer | 01/20/2023 | 47,834 |
Brown Victoria L. | Program Team Lead | 01/20/2023 | 73,495 |
Machiels Alec | Director | 01/17/2023 | 3,338 |
Machiels Alec | Director | 01/17/2023 | 65,525 |
Deschatelets Pascal | Chief Scientific Officer | 01/09/2023 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 01/09/2023 | 552,960 |
Grossi Federico | Chief Medical Officer | 01/05/2023 | 121,975 |
Townsend Adam J. | Chief Commercial Officer | 01/03/2023 | 75,450 |
Townsend Adam J. | Chief Commercial Officer | 01/03/2023 | 253,500 |
Dunlop A. Sinclair | Director | 01/03/2023 | 25,350 |
Deschatelets Pascal | Chief Scientific Officer | 12/29/2022 | 25,690 |
Eisele Jeffrey | Exec VP, Program Team Lead | 12/22/2022 | 4,600 |
Francois Cedric | Chief Executive Officer | 12/19/2022 | 231,680 |
Francois Cedric | Chief Executive Officer | 12/19/2022 | 1,467,983 |
Machiels Alec | Director | 12/15/2022 | 3,338 |
Machiels Alec | Director | 12/15/2022 | 65,437 |
Deschatelets Pascal | Chief Scientific Officer | 12/08/2022 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 12/08/2022 | 570,000 |
Townsend Adam J. | Chief Commercial Officer | 12/05/2022 | 75,450 |
Townsend Adam J. | Chief Commercial Officer | 12/05/2022 | 251,900 |
Dunlop A. Sinclair | Director | 12/01/2022 | 24,965 |
Grossi Federico | Chief Medical Officer | 12/01/2022 | 124,825 |
Machiels Alec | Director | 11/15/2022 | 3,338 |
Machiels Alec | Director | 11/15/2022 | 60,012 |
Deschatelets Pascal | Chief Scientific Officer | 11/08/2022 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 11/08/2022 | 557,640 |
Townsend Adam J. | Chief Commercial Officer | 11/03/2022 | 75,450 |
Townsend Adam J. | Chief Commercial Officer | 11/03/2022 | 292,700 |
Dunlop A. Sinclair | Director | 11/01/2022 | 30,415 |
Grossi Federico | Chief Medical Officer | 11/01/2022 | 152,075 |
Brown Victoria L. | Program Team Lead | 10/26/2022 | 7,593 |
DeLong Mark Jeffrey | Senior Vice President | 10/20/2022 | 11,368 |
Chopas James George | VP/Chief Accounting Officer | 10/20/2022 | 7,540 |
Machiels Alec | Director | 10/14/2022 | 3,338 |
Machiels Alec | Director | 10/14/2022 | 74,138 |
Deschatelets Pascal | Chief Scientific Officer | 10/10/2022 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 10/10/2022 | 690,000 |
Grossi Federico | CHIEF MEDICAL OFFICER | 10/03/2022 | 166,725 |
Townsend Adam J. | Chief Commercial Officer | 10/03/2022 | 75,450 |
Townsend Adam J. | Chief Commercial Officer | 10/03/2022 | 333,450 |
Machiels Alec | Director | 09/15/2022 | 3,338 |
Machiels Alec | Director | 09/15/2022 | 82,500 |
Deschatelets Pascal | Chief Scientific Officer | 09/08/2022 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 09/08/2022 | 767,760 |
Dunlop A. Sinclair | Director | 09/08/2022 | 975,000 |
Townsend Adam J. | Chief Commercial Officer | 09/06/2022 | 75,450 |
Townsend Adam J. | Chief Commercial Officer | 09/06/2022 | 301,900 |
Grossi Federico | CHIEF MEDICAL OFFICER | 09/01/2022 | 150,750 |
Chopas James George | VP/Chief Accounting Officer | 08/30/2022 | 32,833 |
Dunlop A. Sinclair | Director | 08/25/2022 | 56,796 |
DeLong Mark Jeffrey | Senior Vice President | 08/17/2022 | 77,600 |
DeLong Mark Jeffrey | Senior Vice President | 08/17/2022 | 347,500 |
Dunlop A. Sinclair | Director | 08/16/2022 | 355,516 |
Townsend Adam J. | Chief Commercial Officer | 08/15/2022 | 188,625 |
Townsend Adam J. | Chief Commercial Officer | 08/15/2022 | 862,500 |
Machiels Alec | Director | 08/15/2022 | 3,338 |
Machiels Alec | Director | 08/15/2022 | 84,012 |
Townsend Adam J. | Chief Commercial Officer | 08/11/2022 | 188,625 |
Townsend Adam J. | Chief Commercial Officer | 08/11/2022 | 837,500 |
DeLong Mark Jeffrey | Senior Vice President | 08/11/2022 | 77,600 |
DeLong Mark Jeffrey | Senior Vice President | 08/11/2022 | 335,000 |
Dunlop A. Sinclair | Director | 08/11/2022 | 1,968,900 |
Townsend Adam J. | Chief Commercial Officer | 08/08/2022 | 188,625 |
Townsend Adam J. | Chief Commercial Officer | 08/08/2022 | 812,500 |
Deschatelets Pascal | Chief Scientific Officer | 08/08/2022 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 08/08/2022 | 750,000 |
DeLong Mark Jeffrey | Senior Vice President | 08/08/2022 | 77,600 |
DeLong Mark Jeffrey | Senior Vice President | 08/08/2022 | 322,500 |
DeLong Mark Jeffrey | Senior Vice President | 08/04/2022 | 155,200 |
DeLong Mark Jeffrey | Senior Vice President | 08/04/2022 | 607,500 |
Townsend Adam J. | Chief Commercial Officer | 08/03/2022 | 75,450 |
Townsend Adam J. | Chief Commercial Officer | 08/03/2022 | 282,150 |
Grossi Federico | CHIEF MEDICAL OFFICER | 08/01/2022 | 139,975 |
DeLong Mark Jeffrey | Senior Vice President | 07/27/2022 | 77,600 |
DeLong Mark Jeffrey | Senior Vice President | 07/27/2022 | 285,000 |
Dunlop A. Sinclair | Director | 07/21/2022 | 134,484 |
DeLong Mark Jeffrey | Senior Vice President | 07/19/2022 | 77,600 |
DeLong Mark Jeffrey | Senior Vice President | 07/19/2022 | 282,100 |
Machiels Alec | Director | 07/15/2022 | 3,338 |
Machiels Alec | Director | 07/15/2022 | 57,913 |
Townsend Adam J. | Chief Commercial Officer | 07/11/2022 | 75,450 |
Townsend Adam J. | Chief Commercial Officer | 07/11/2022 | 242,100 |
Deschatelets Pascal | Chief Scientific Officer | 07/08/2022 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 07/08/2022 | 575,400 |
Dunlop A. Sinclair | Director | 06/27/2022 | 62,743 |
Dunlop A. Sinclair | Director | 06/23/2022 | 675,000 |
Watson David O. | General Counsel | 06/22/2022 | 445,140 |
Deschatelets Pascal | Chief Scientific Officer | 06/17/2022 | 88,123 |
Brown Victoria L. | Program Team Lead | 06/17/2022 | 121,410 |
DeLong Mark Jeffrey | Senior Vice President | 06/16/2022 | 138,500 |
DeLong Mark Jeffrey | Senior Vice President | 06/16/2022 | 417,850 |
Machiels Alec | Director | 06/15/2022 | 3,338 |
Machiels Alec | Director | 06/15/2022 | 49,113 |
Deschatelets Pascal | Chief Scientific Officer | 06/08/2022 | 49,395 |
Deschatelets Pascal | Chief Scientific Officer | 06/08/2022 | 529,080 |
Grossi Federico | CHIEF MEDICAL OFFICER | 06/01/2022 | 104,450 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 05/27/2022 | 430,000 |
Machiels Alec | Director | 05/16/2022 | 3,338 |
Machiels Alec | Director | 05/16/2022 | 48,975 |
Grossi Federico | CHIEF MEDICAL OFFICER | 05/02/2022 | 108,900 |
Deschatelets Pascal | Chief Scientific Officer | 04/29/2022 | 10,680 |
Deschatelets Pascal | Chief Scientific Officer | 04/29/2022 | 177,720 |
Watson David O. | General Counsel | 04/25/2022 | 250,000 |
Dunlop A. Sinclair | Director | 04/22/2022 | 280,000 |
DeLong Mark Jeffrey | Senior Vice President | 04/20/2022 | 108,640 |
DeLong Mark Jeffrey | Senior Vice President | 04/20/2022 | 367,710 |
Machiels Alec | Director | 04/14/2022 | 3,338 |
Machiels Alec | Director | 04/14/2022 | 63,625 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 04/05/2022 | 8,435 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 04/05/2022 | 36,593 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 04/04/2022 | 48,530 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 04/04/2022 | 199,589 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 04/01/2022 | 159,220 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 04/01/2022 | 632,855 |
Brown Victoria L. | Program Team Lead | 03/25/2022 | 4,041 |
Machiels Alec | Director | 03/15/2022 | 3,338 |
Machiels Alec | Director | 03/15/2022 | 49,462 |
Grossi Federico | CHIEF MEDICAL OFFICER | 03/15/2022 | 30,170 |
Grossi Federico | CHIEF MEDICAL OFFICER | 03/15/2022 | 14,839 |
Grossi Federico | CHIEF MEDICAL OFFICER | 03/01/2022 | 16,324 |
Grossi Federico | CHIEF MEDICAL OFFICER | 02/23/2022 | 17,671 |
Grossi Federico | CHIEF MEDICAL OFFICER | 02/15/2022 | 17,036 |
Machiels Alec | Director | 02/15/2022 | 3,338 |
Machiels Alec | Director | 02/15/2022 | 56,788 |
Grossi Federico | CHIEF MEDICAL OFFICER | 02/14/2022 | 15,516 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 02/14/2022 | 19,246 |
Watson David O. | General Counsel | 02/10/2022 | 23,136 |
Grossi Federico | CHIEF MEDICAL OFFICER | 02/10/2022 | 33,220 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 02/08/2022 | 138,500 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 02/08/2022 | 450,000 |
Grossi Federico | CHIEF MEDICAL OFFICER | 02/01/2022 | 15,218 |
Brown Victoria L. | Program Team Lead | 01/28/2022 | 16,748 |
DeLong Mark Jeffrey | Senior Vice President | 01/28/2022 | 16,748 |
Eisele Jeffrey | Exec VP, Program Team Lead | 01/28/2022 | 16,748 |
Grossi Federico | CHIEF MEDICAL OFFICER | 01/28/2022 | 25,084 |
Nicholson Nur | Chief Technical Officer | 01/28/2022 | 25,084 |
Sullivan Timothy Eugene | Chief Financial Officer | 01/28/2022 | 25,084 |
Watson David O. | General Counsel | 01/28/2022 | 25,084 |
Townsend Adam J. | Chief Commercial Officer | 01/28/2022 | 30,872 |
Deschatelets Pascal | Chief Scientific Officer | 01/28/2022 | 35,927 |
Francois Cedric | Chief Executive Officer | 01/28/2022 | 78,106 |
Lewis Karen | Chief People Officer | 01/28/2022 | 16,748 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 01/28/2022 | 24,775 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 01/31/2022 | 47,434 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 01/21/2022 | 80,751 |
Machiels Alec | Director | 01/14/2022 | 3,338 |
Machiels Alec | Director | 01/14/2022 | 50,700 |
Grossi Federico | CHIEF MEDICAL OFFICER | 01/14/2022 | 14,654 |
Grossi Federico | CHIEF MEDICAL OFFICER | 01/14/2022 | 15,210 |
Grossi Federico | CHIEF MEDICAL OFFICER | 01/12/2022 | 20,230 |
Grossi Federico | CHIEF MEDICAL OFFICER | 01/03/2022 | 17,741 |
Watson David O. | General Counsel | 12/27/2021 | 58,200 |
Watson David O. | General Counsel | 12/22/2021 | 289,674 |
Watson David O. | General Counsel | 12/22/2021 | 505,373 |
Eisele Jeffrey | Exec VP, Program Team Lead | 12/22/2021 | 4,256 |
Grossi Federico | CHIEF MEDICAL OFFICER | 12/15/2021 | 16,080 |
Machiels Alec | Director | 12/15/2021 | 8,010 |
Machiels Alec | Director | 12/15/2021 | 128,640 |
Grossi Federico | CHIEF MEDICAL OFFICER | 12/08/2021 | 26,320 |
Grossi Federico | CHIEF MEDICAL OFFICER | 12/01/2021 | 15,900 |
Morningside Venture Investments Ltd | 10% Owner | 11/18/2021 | 10,000,000 |
Grossi Federico | CHIEF MEDICAL OFFICER | 11/15/2021 | 27,188 |
Machiels Alec | Director | 11/04/2021 | 8,010 |
Machiels Alec | Director | 11/15/2021 | 8,010 |
Machiels Alec | Director | 11/04/2021 | 105,000 |
Machiels Alec | Director | 11/15/2021 | 130,500 |
Grossi Federico | CHIEF MEDICAL OFFICER | 11/01/2021 | 19,188 |
Grossi Federico | CHIEF MEDICAL OFFICER | 10/14/2021 | 25,927 |
Grossi Federico | CHIEF MEDICAL OFFICER | 10/01/2021 | 24,945 |
Grossi Federico | CHIEF MEDICAL OFFICER | 09/28/2021 | 15,040 |
Dunlop A. Sinclair | Director | 09/10/2021 | 96,516 |
Watson David O. | General Counsel | 09/10/2021 | 4,112 |
Machiels Alec | Director | 08/16/2021 | 6,675 |
Machiels Alec | Director | 08/16/2021 | 142,375 |
Grossi Federico | CHIEF MEDICAL OFFICER | 08/02/2021 | 15,998 |
Perry Nicole D | Vice President - Accounting | 08/02/2021 | 3,760 |
Perry Nicole D | Vice President - Accounting | 08/02/2021 | 63,990 |
DeLong Mark Jeffrey | Senior Vice President | 07/21/2021 | 15,520 |
DeLong Mark Jeffrey | Senior Vice President | 07/21/2021 | 65,000 |
Francois Cedric | Chief Executive Officer | 07/21/2021 | 62,107 |
DeLong Mark Jeffrey | Senior Vice President | 07/15/2021 | 15,520 |
DeLong Mark Jeffrey | Senior Vice President | 07/15/2021 | 62,300 |
Machiels Alec | Director | 07/15/2021 | 6,675 |
Machiels Alec | Director | 07/15/2021 | 155,750 |
Grossi Federico | CHIEF MEDICAL OFFICER | 07/14/2021 | 32,340 |
Grossi Federico | CHIEF MEDICAL OFFICER | 07/08/2021 | 16,420 |
Grossi Federico | CHIEF MEDICAL OFFICER | 06/28/2021 | 33,840 |
Deschatelets Pascal | Chief Scientific Officer | 06/24/2021 | 16,688 |
Deschatelets Pascal | Chief Scientific Officer | 06/24/2021 | 410,063 |
Machiels Alec | Director | 06/15/2021 | 6,675 |
Machiels Alec | Director | 06/15/2021 | 162,075 |
Grossi Federico | CHIEF MEDICAL OFFICER | 06/14/2021 | 30,920 |
Machiels Alec | Director | 05/14/2021 | 6,675 |
Machiels Alec | Director | 05/14/2021 | 113,475 |
Grossi Federico | CHIEF MEDICAL OFFICER | 05/03/2021 | 30,438 |
Deschatelets Pascal | Chief Scientific Officer | 04/28/2021 | 12,015 |
Deschatelets Pascal | Chief Scientific Officer | 04/23/2021 | 16,688 |
Deschatelets Pascal | Chief Scientific Officer | 04/23/2021 | 288,313 |
Watson David O. | General Counsel | 04/22/2021 | 2,108 |
Machiels Alec | Director | 04/21/2021 | 6,675 |
Machiels Alec | Director | 04/21/2021 | 114,400 |
Dunlop A. Sinclair | Director | 04/16/2021 | 700,000 |
Grossi Federico | CHIEF MEDICAL OFFICER | 04/14/2021 | 21,410 |
Grossi Federico | CHIEF MEDICAL OFFICER | 04/01/2021 | 26,046 |
Brown Victoria L. | Program Team Lead | 03/25/2021 | 3,375 |
Watson David O. | General Counsel | 03/22/2021 | 4,215 |
Machiels Alec | Director | 03/15/2021 | 6,675 |
Machiels Alec | Director | 03/15/2021 | 116,925 |
Grossi Federico | CHIEF MEDICAL OFFICER | 03/15/2021 | 23,385 |
Deschatelets Pascal | Chief Scientific Officer | 03/10/2021 | 16,688 |
Deschatelets Pascal | Chief Scientific Officer | 03/10/2021 | 317,125 |
Grossi Federico | CHIEF MEDICAL OFFICER | 03/05/2021 | 16,000 |
Grossi Federico | CHIEF MEDICAL OFFICER | 03/05/2021 | 243,075 |
Perry Nicole D | Vice President - Accounting | 03/01/2021 | 7,520 |
Perry Nicole D | Vice President - Accounting | 03/01/2021 | 100,000 |
Grossi Federico | CHIEF MEDICAL OFFICER | 03/01/2021 | 29,148 |
Grossi Federico | CHIEF MEDICAL OFFICER | 02/16/2021 | 23,000 |
Machiels Alec | Director | 02/16/2021 | 6,675 |
Machiels Alec | Director | 02/16/2021 | 115,000 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 02/10/2021 | 32,450 |
Sullivan Timothy Eugene | Chief Financial Officer | 02/10/2021 | 40,944 |
Perry Nicole D | Vice President - Accounting | 02/10/2021 | 7,301 |
Deschatelets Pascal | Chief Scientific Officer | 02/10/2021 | 32,831 |
Townsend Adam J. | Chief Commercial Officer | 02/10/2021 | 32,831 |
Brown Victoria L. | Program Team Lead | 02/10/2021 | 6,872 |
Grossi Federico | CHIEF MEDICAL OFFICER | 02/10/2021 | 32,831 |
Francois Cedric | Chief Executive Officer | 02/10/2021 | 120,398 |
Francois Cedric | Chief Executive Officer | 02/10/2021 | 120,398 |
Watson David O. | General Counsel | 02/10/2021 | 22,333 |
Perry Nicole D | Vice President - Accounting | 02/09/2021 | 7,520 |
Perry Nicole D | Vice President - Accounting | 02/09/2021 | 100,000 |
Grossi Federico | CHIEF MEDICAL OFFICER | 02/01/2021 | 26,400 |
Francois Cedric | Chief Executive Officer | 01/27/2021 | 287,477 |
Watson David O. | General Counsel | 01/27/2021 | 174,519 |
Grossi Federico | CHIEF MEDICAL OFFICER | 01/25/2021 | 54,440 |
Machiels Alec | Director | 01/15/2021 | 6,675 |
Machiels Alec | Director | 01/15/2021 | 132,875 |
Grossi Federico | CHIEF MEDICAL OFFICER | 01/14/2021 | 207,960 |
Grossi Federico | CHIEF MEDICAL OFFICER | 01/04/2021 | 34,344 |
Perry Nicole D | Vice President - Accounting | 01/04/2021 | 7,520 |
Perry Nicole D | Vice President - Accounting | 01/04/2021 | 114,480 |
Machiels Alec | Director | 12/15/2020 | 6,675 |
Machiels Alec | Director | 12/15/2020 | 130,400 |
Francois Cedric | Chief Executive Officer | 12/15/2020 | 260,800 |
Dunlop A. Sinclair | Director | 12/14/2020 | 1,366,713 |
Watson David O. | General Counsel | 12/11/2020 | 137,600 |
Watson David O. | General Counsel | 12/14/2020 | 116,312 |
Watson David O. | General Counsel | 12/14/2020 | 437,197 |
Watson David O. | General Counsel | 12/11/2020 | 496,750 |
SCHEIBLER LUKAS | CHIEF INNOVATION OFFICER | 12/08/2020 | 199,994 |
Perry Nicole D | Vice President - Accounting | 12/04/2020 | 67,680 |
Perry Nicole D | Vice President - Accounting | 12/04/2020 | 900,000 |
Grossi Federico | CHIEF MEDICAL OFFICER | 12/04/2020 | 23,200 |
Dunlop A. Sinclair | Director | 12/07/2020 | 941,399 |
Dunlop A. Sinclair | Director | 12/04/2020 | 323,455 |
Francois Cedric | Chief Executive Officer | 12/01/2020 | 150,400 |
Grossi Federico | CHIEF MEDICAL OFFICER | 12/01/2020 | 28,950 |
Francois Cedric | Chief Executive Officer | 11/16/2020 | 196,900 |
Machiels Alec | Director | 11/16/2020 | 6,675 |
Machiels Alec | Director | 11/16/2020 | 98,450 |
Grossi Federico | CHIEF MEDICAL OFFICER | 11/16/2020 | 18,400 |
Grossi Federico | CHIEF MEDICAL OFFICER | 11/02/2020 | 18,654 |
Machiels Alec | Director | 10/15/2020 | 6,675 |
Machiels Alec | Director | 10/15/2020 | 87,500 |
Francois Cedric | Chief Executive Officer | 10/15/2020 | 172,300 |
Machiels Alec | Director | 10/07/2020 | 20,025 |
Machiels Alec | Director | 10/07/2020 | 262,500 |
Brown Victoria L. | Program Team Lead | 10/07/2020 | 227,760 |
Brown Victoria L. | Program Team Lead | 10/07/2020 | 420,000 |
Grossi Federico | See Remarks | 10/01/2020 | 18,132 |
Francois Cedric | Chief Executive Officer | 09/15/2020 | 154,800 |
Grossi Federico | See Remarks | 09/01/2020 | 18,948 |
Francois Cedric | Chief Executive Officer | 08/20/2020 | 103,710 |
Francois Cedric | Chief Executive Officer | 08/18/2020 | 46,290 |
Grossi Federico | See Remarks | 08/03/2020 | 15,768 |
Francois Cedric | Chief Executive Officer | 07/15/2020 | 160,600 |
Grossi Federico | See Remarks | 07/01/2020 | 27,566 |
Grossi Federico | See Remarks | 06/15/2020 | 25,860 |
Machiels Alec | Director | 06/15/2020 | 6,675 |
Machiels Alec | Director | 06/15/2020 | 75,525 |
Francois Cedric | Chief Executive Officer | 06/15/2020 | 151,050 |
Francois Cedric | Chief Executive Officer | 05/15/2020 | 149,600 |
Machiels Alec | Director | 05/15/2020 | 6,675 |
Machiels Alec | Director | 05/15/2020 | 75,000 |
FONTEYNE PAUL R. | Director | 05/08/2020 | 159,034 |
Francois Cedric | Chief Executive Officer | 04/15/2020 | 148,850 |
Machiels Alec | Director | 04/15/2020 | 6,675 |
Machiels Alec | Director | 04/15/2020 | 75,000 |
Machiels Alec | Director | 03/25/2020 | 6,675 |
Machiels Alec | Director | 03/25/2020 | 75,000 |
Francois Cedric | Chief Executive Officer | 03/17/2020 | 65,563 |
Francois Cedric | Chief Executive Officer | 03/16/2020 | 65,563 |
Francois Cedric | Chief Executive Officer | 03/16/2020 | 759,934 |
Francois Cedric | Chief Executive Officer | 02/18/2020 | 65,563 |
Francois Cedric | Chief Executive Officer | 02/19/2020 | 65,563 |
Francois Cedric | Chief Executive Officer | 02/18/2020 | 1,449,122 |
Machiels Alec | Director | 02/14/2020 | 6,675 |
Machiels Alec | Director | 02/14/2020 | 105,875 |
Deschatelets Pascal | Chief Operating Officer | 02/12/2020 | 250,821 |
Deschatelets Pascal | Chief Operating Officer | 02/13/2020 | 250,819 |
Deschatelets Pascal | Chief Operating Officer | 02/12/2020 | 2,228,966 |
Deschatelets Pascal | Chief Operating Officer | 02/13/2020 | 2,270,155 |
Watson David O. | General Counsel | 02/10/2020 | 20,038 |
Watson David O. | General Counsel | 02/10/2020 | 222,500 |
Watson David O. | General Counsel | 01/27/2020 | 40,050 |
Watson David O. | General Counsel | 01/27/2020 | 121,401 |
Morningside Venture Investments Ltd | 10% Owner | 01/13/2020 | 19,999,980 |
Francois Cedric | Chief Executive Officer | 01/16/2020 | 65,563 |
Francois Cedric | Chief Executive Officer | 01/15/2020 | 65,565 |
Francois Cedric | Chief Executive Officer | 01/15/2020 | 1,500,788 |
Machiels Alec | Director | 01/15/2020 | 6,675 |
Machiels Alec | Director | 01/15/2020 | 103,675 |
Dunlop A. Sinclair | Director | 12/19/2019 | 2,483,459 |
Dunlop A. Sinclair | Director | 12/18/2019 | 739,159 |
Dunlop A. Sinclair | Director | 12/20/2019 | 738,250 |
Francois Cedric | Chief Executive Officer | 12/16/2019 | 139,750 |
Francois Cedric | Chief Executive Officer | 11/15/2019 | 136,405 |
Francois Cedric | Chief Executive Officer | 10/15/2019 | 131,551 |
Deschatelets Pascal | Chief Operating Officer | 09/25/2019 | 544,059 |
Deschatelets Pascal | Chief Operating Officer | 09/23/2019 | 522,915 |
Deschatelets Pascal | Chief Operating Officer | 09/24/2019 | 531,081 |
Francois Cedric | Chief Executive Officer | 09/16/2019 | 132,949 |
Sullivan Timothy Eugene | Chief Financial Officer | 08/29/2019 | 347,630 |
Francois Cedric | Chief Executive Officer | 08/23/2019 | 100,138 |
Francois Cedric | Chief Executive Officer | 08/15/2019 | 21,400 |
Francois Cedric | Chief Executive Officer | 08/15/2019 | 268,007 |
Watson David O. | General Counsel | 08/07/2019 | 13,350 |
Francois Cedric | Chief Executive Officer | 06/27/2019 | 588,500 |
Morningside Venture Investments Ltd | 10% Owner | 03/11/2019 | 7,499,992 |
Grossi Federico | See Remarks | 11/14/2018 | 20,000 |
Axon Steven | Chief Business Officer | 11/14/2018 | 29,785 |
Morningside Venture Investments Ltd | 10% Owner | 09/20/2018 | 790,363 |
Morningside Venture Investments Ltd | 10% Owner | 09/21/2018 | 793,600 |
Morningside Venture Investments Ltd | 10% Owner | 09/19/2018 | 1,085,400 |
Morningside Venture Investments Ltd | 10% Owner | 09/18/2018 | 738,800 |
Morningside Venture Investments Ltd | 10% Owner | 09/17/2018 | 742,924 |
Watson David O. | General Counsel | 09/14/2018 | 87,624 |
Watson David O. | General Counsel | 09/14/2018 | 296,336 |
Watson David O. | General Counsel | 05/29/2018 | 1,666 |
SCHEIBLER LUKAS | See Remarks | 05/24/2018 | 59,786 |
Grossi Federico | See Remarks | 04/11/2018 | 27,200 |
Axon Steven | Chief Business Officer | 02/20/2018 | 100,000 |
Hillhouse Capital Management, Ltd. | 10% Owner | 11/13/2017 | 19,999,994 |
Cormorant Asset Management, LLC | 10% Owner | 11/13/2017 | 14,999,992 |
venBio Global Strategic Fund II L.P. | 10% Owner | 11/13/2017 | 1,785,210 |
Morningside Venture Investments Ltd | 10% Owner | 11/13/2017 | 8,050,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 5,381,253 | 0.00821% | 2.06% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,630,642 | 0.01% | 4.88% | Other |
ORBIMED ADVISORS LLC | 922,200 | 1.1% | -26.84% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 481,501 | 0.35% | 165.55% | Growth |
CANDRIAM S.C.A. | 337,507 | 0.14% | 3.37% | Other |
TIG ADVISORS, LLC | 156,100 (Call) | 1.17% | New | Event Driven |
TIG ADVISORS, LLC | 53,400 (Put) | 0.4% | New | Event Driven |
D. E. SHAW & CO., INC. | 33,086 | 0.00173% | -16.18% | Other |
D. E. SHAW & CO., INC. | 29,500 (Call) | 0.00154% | No change | Other |
UBS OCONNOR LLC | 25,000 (Call) | 0.00854% | -50% | Value |
TIG ADVISORS, LLC | 17,093 | 0.13% | New | Event Driven |
TUDOR INVESTMENT CORP ET AL | 9,962 | 0.0048% | -80.12% | Event Driven, Other |
HARVEST MANAGEMENT LLC | 7,000 (Put) | 0.39% | New | Event Driven |
FARALLON CAPITAL MANAGEMENT LLC | 6,000 | 0.00178% | -96.91% | Event Driven, Value |
GOTHAM ASSET MANAGEMENT, LLC | 3,513 | 0.0039% | New | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View